Page last updated: 2024-08-24

lamivudine and indinavir sulfate

lamivudine has been researched along with indinavir sulfate in 310 studies

Research

Studies (310)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	146 (47.10)	18.2507
2000's	152 (49.03)	29.6817
2010's	11 (3.55)	24.3611
2020's	1 (0.32)	2.80

Authors

Authors	Studies
D'Aquila, RT; De Pasquale, MP; Olson, DP; Scadden, DT	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Barry, DW; Pennington, KN; Rooney, J; St Clair, MH	1
Rowe, PM	1
Beardsley, T	1
Patrick, DM	1
Hirschel, B; Rutschmann, O	1
Boulton, A	1
Craib, K; Gataric, N; Hogg, RS; Montaner, JS; O'Shaughnessy, MV; Schechter, MT; Yip, B	1
Heylen, R; Miller, R	1
Jacobson, MA; O'Donnell, JJ; Owens, S; Pavan, PR; Pollard, R; Rao, N; Sattler, F; Zegans, M	1
Domingo, P; Guardiola, JM; Iranzo, A; Margall, N	1
Mueller, BU	1
Collins, DO; Sakamoto, A	1
Clavel, F; Dupont, B; Fournier, S; Moulignier, A; Pialoux, G; Poveda, JD	1
Chenoweth, CE; Gobetti, JP	1
Balfour, HH; Chodakewitz, JA; Currier, JS; Demeter, LM; Deyton, LR; Eron, JJ; Feinberg, JE; Fischl, MA; Grimes, JM; Hammer, SM; Hughes, MD; Squires, KE	1
Chodakewitz, JA; Emini, EA; Eron, JJ; Gonzalez, C; Gulick, RM; Havlir, D; Jonas, L; McMahon, D; Meibohm, A; Mellors, JW; Richman, DD; Valentine, FT	1
Escribano Hernández, A	1
Feingold, A; Meislich, D; Rudy, B; Rutstein, RM; Word, B	1
Cottalorda, J; Lefbvre, JC; Mariani, R; Monpoux, F; Sirvent, N	1
Emini, E; Günthard, HF; Haase, AT; Havlir, DV; Ignacio, CC; Kwok, S; Richman, DD; Wong, JK; Zhang, ZQ	1
Günthard, HF; Havlir, DV; Hezareh, M; Ignacio, CC; Richman, DD; Spina, CA; Wong, JK	1
Casas, E; Gómez-Cano, M; González-Lahoz, J; Soriano, V; Valencia, E; Villalba, N	1
Izopet, J; Marchou, B; Massip, P; Pasquier, C; Puel, J; Sandres, K; Tamalet, C	1
Hauri, D; John, H; Müller, NJ; Opravil, M	1
Gisslén, M; Hagberg, L; Norkrans, G; Svennerholm, B	1
Chapanduka, ZC; Matchaba, PT	1
Back, DJ; Barry, MG; Hoggard, PG; Manion, V	1
Guatelli, JC; Günthard, HF; Havlir, DV; Ignacio, CC; Richman, DD; Riggs, NL; Wong, JK	1
Gray, CM; Merigan, TC; Schapiro, JM; Winters, MA	1
Conway, B; Durakovic, C; Fransen, S; Harris, M; Montaner, JS; Raboud, J; Rae, S; Shillington, A	1
Blanchard, G; Blum, L; Calvo, F; Danne, O; Lebbé, C; Morel, P; Pellet, C; Vérola, O	1
Aboulker, JP; Batisse, D; Belec, L; Castiel, P; Gilquin, J; Gonzalez-Canali, G; Jayle, D; Karmochkine, M; Kazatchkine, MD; Piketty, C; Si Mohamed, A; Weiss, L	1
Batisse, D; Belec, L; Karmochkine, M; Kazatchkine, MD; Piketty, C; Si Mohamed, A	1
Duchatelle, V; Durand, F; Hermine, O; Karras, A; Rabian, C; Valla, D; Viard, JP; Zylberberg, H	1
Kaiser, R; Rockstroh, JK; Sauerbruch, T; Spengler, U; Theisen, A	1
Balis, FM; Brouwers, P; Deutsch, PJ; Jarosinski, PF; Ju, W; Mistry, G; Mueller, BU; Nelson, RP; Pizzo, PA; Sei, S; Sleasman, J; Smith, S; Steinberg, SM; Winchell, G; Wood, LV; Zeichner, S; Zwerski, S	1
Belohradsky, BH; Eberle, J; Gürtler, L; Hoffmann, F; Notheis, G; Petropoulou, T; Sölder, B; Wintergerst, U	1
Jürgens, H; Pollmann, H; Richter, H	1
Chodakewitz, JA; Condra, JH; Emini, EA; Eron, JJ; Gonzalez, C; Gulick, RM; Havlir, D; Holder, D; Isaacs, R; Jonas, L; McMahon, D; Meibohm, A; Mellors, JW; Richman, DD; Schleif, WA	1
Frothingham, R	1
Berrey, MM; Chun, TW; Corey, L; Engel, D; Fauci, AS; Shea, T	1
Danner, SA; de Wolf, F; Goudsmit, J; Hoetelmans, RM; Jurriaans, S; Lange, JM; Lukashov, VV; Notermans, DW; Prins, JM; Roos, M; Schuitemaker, H; Weverling, GJ	1
Bellman, PC	1
Carpenter, WM; Cuny, E	1
Kibayashi, K; NG'walali, PM; Tsunenari, S	1
Fuchs, D; Gisslén, M; Hagberg, L; Svennerholm, B	1
de Jong, JJ; de Wolf, F; Foudraine, NA; Jan Weverling, G; Jurriaans, S; Keet, IP; Lange, JM; Maas, J; Roos, MT; van Benthem, BH; Vandermeulen, K	1
Bogner, JR; Goebel, F; Jung, C	1
Bachmeyer, C; Blum, L	1
Heald, AE; Pieper, CF; Schiffman, SS	1
Collazos, J; Martínez, E; Mayo, J	1
Saag, MS; Schooley, RT	1
Lindbloom, EJ; Stevermer, JJ	1
Bassett, RL; Boone, G; Collier, AC; Havlir, DV; Hirsch, MS; Holohan, MK; Ioannidis, JP; Leavitt, R; Marschner, IC; Richman, DD; Tebas, P	1
Aboulker, JP; Brun-Vezinet, F; Delfraissy, JF; Dellamonica, P; Flandre, P; Gastaut, JA; Meiffrédy, V; Pialoux, G; Raffi, F; Yeni, P	1
Che, M; Coulter, CL; Gendelman, HE; Ghorpade, A; Hahn, F; Persidsky, Y; Reinhard, J; Rubocki, R; Swindells, S; Thylin, M; Zheng, J	1
Bréchot, C; Carnot, F; Landau, A; Pialoux, G; Pol, S; Zylberberg, H	1
Bonnez, W; Evans, TG; Fitzgerald, T; Gibbons, DC; Reichman, RC; Soucier, HR	1
Gitterman, SR; Pratt, RD; Struble, KA	1
Mayers, DL	1
Izopet, J; Marchou, B; Massip, P; Pasquier, C; Puel, J; Salama, G; Sandres, K	1
Clerici, M; Ferrante, P; Rusconi, S; Saresella, M; Viganó, A	1
Brew, BJ; Markus, R	1
Gilquin, J; Jubault, V; Kazatchkine, MD; Sert, C; Viard, JP	1
Flexman, J; French, MA; John, M	1
Clark, NM; Dieng Sarr, A; Kanki, PJ; Kazanjian, P; Markovitz, DM; Sankalé, JL; Winfield, R	1
Al-Shboul, Q; Day, RD; Fan, Z; Huang, XL; Liebmann, JM; McMahon, DK; Mellors, JW; Riddler, SA; Rinaldo, CR	1
Béguinot, I; Dehlinger, V; Etienne, JC; Jaussaud, R; Léone, J; Pennaforte, JL; Rouger, C; Strady, C	1
Baron, F; Daniel, C; Moutschen, M	1
Borleffs, JC; Boucher, CA; Cohen Stuart, JW; Hamman, D; Miedema, F; Roos, M	1
Lawrence, J; Merigan, TC; Schapiro, JM; Winters, MA	1
Justesen, US; Mygind, LH; Pedersen, C; Pedersen, SS	1
Hosaka, H; Kubo, S; Nagai, K; Nakamura, N; Nonaka, H; Shinohara, M	1
Chodakewitz, J; Cook, J; Coplan, P; Dasbach, E; Markson, L; Meibohm, A; Mellors, J; Nguyen, BY; Yin, D	1
Bricaire, F	1
Bettoli, V; D'Antuono, A; Marzaduri, S; Piraccini, BM; Tosti, A	1
Borleffs, JC; Boucher, CA; Bravenboer, B; Burger, DM; Cohen Stuart, JW; Hamann, D; Hoetelmans, RM; Juttmann, JR; Koopmans, PP; Kroon, FP; Meenhorst, PL; Richter, C; Schuurman, R; Sprenger, HG	1
Carr, A; Cooper, DA; Cunningham, PH; Grey, P; Jaramillo, AB; Kaufmann, GR; Kelleher, AD; Smith, D; Vizzard, J; Wright, R; Zaunders, JJ	1
Fine, N; Hurwitz, JJ; Rachlis, AR	1
Agut, H; Autran, B; Calvez, V; Katlama, C; Li, TS; Neumann, AU; Robert, C; Tubiana, R	1
Goulder, PJ; Jones, NG; Kalams, SA; Ogg, GS; Shea, AK; Trocha, AK; Walker, BD	1
Hogg, RS; Jahnke, N; Montaner, JS; O'Shaughnessy, M; Yip, B	1
Hirsch, M; Hirschel, B; Lange, J; Leavitt, R; Meibohm, A; Mellors, J; Rawlins, S; Scerpella, E; Squires, K; Staszewski, S; Steigbigel, R	1
Ahmad, M; Brennan, JM; Caliendo, AM; Fiske, WD; Flanigan, TP; Gormley, JM; Tashima, KT	1
Bloch, M; Carr, A; Cunningham, P; Smith, D; Vasak, E	1
Carlo, DJ; Kaplan, MH; Marecki, M; Moss, RB; Patterson, BK; Pawha, S	1
Kan, VL; Nylen, ES	1
Black, FT; Blaxhult, A; Gerstoft, J; Jensen-Fangel, S; Kirk, O; Larsen, L; Lundgren, JD; Obel, N; Pedersen, C	1
Wood, LV	1
Bricalli, D; Clerici, M; Dally, L; Pirillo, M; Principi, N; Sala, N; Saresella, M; Trabattoni, D; Vella, S; Viganò, A	1
Temesgen, Z; Wright, AJ	1
Asjö, B; Dyrhol-Riise, AM; Olofsson, J; Voltersvik, P	1
Farina, D; Johnson, P; Labriola, DF; Manion, DJ; Morales-Ramirez, J; Rachlis, A; Ruiz, NM; Skiest, D; Stanford, J; Staszewski, S; Stryker, R; Tashima, KT	1
Flepp, M; Jost, J; Ledergerber, B; Opravil, M; Paris, D; Ruef, C; Weber, R; Zimmerli, S	1
Borleffs, JC; Boucher, CA; de Boer, RJ; Hamann, D; Hazenberg, MD; Miedema, F; Otto, SA; Stuart, JW	1
Ap, S; Berrey, MM; Brown, DJ; Corey, L; Huang, Y; Malhotra, U; Markee, J; McElrath, MJ; Musey, L; Schacker, T	1
Arnedo, A; Gómez, CJ; Roca, B	2
Arts, EJ; García Lerma, JG; Heneine, W; Mas, A; Quiñones-Mateu, ME; Soriano, V	1
Staszewski, S	1
Katlama, C	1
Aboulker, JP; Bazin, B; Brun-Vézinet, F; Calvez, V; Collin, G; Delaugerre, C; Descamps, D; Flandre, P; Meiffredy, V; Peytavin, G; Pialoux, G; Raffi, F; Robert-Delmas, S	1
Collier, AC; Havlir, DV; Hellmann, NS; Hirsch, MS; Petropoulos, CJ; Richman, DD; Sommadossi, JP; Tebas, P; Whitcomb, JM	1
Fujimatsu, Y; Fukahori, S; Honda, J; Jojima, H; Oizumi, K; Okubo, Y; Shiraishi, K; Tanaka, K; Tanaka, M	1
Lucchesi, C; Simini, B	1
Bassetti, D; Bassetti, M; Gatti, G; Principi, N; Sala, N; Vella, S; Vigano', A	1
Hirsch, MS; Merrill, DP; Oh, MD	1
Del Valle, S; Palumbo, AM; Scapellato, PG	1
Gil Aguado, A; González Lahoz, J; Lavilla Uriol, P; Valencia Ortega, ME	1
Campi, G; Casorati, G; Corey, L; Demarest, JF; Kaufmann, D; Lazzarin, A; Lenge, C; Pantaleo, G; Rizzardi, GP; Soudeyns, H; Tambussi, G	1
Anderson, J; El-Gadi, S; Forster, G; Murphy, M; Parkin, JM; Pinching, AJ	1
Asjö, B; Dyrhol-Riise, AM; Olofsson, J; Røsok, BI; Voltersvik, P	1
Andreotti, M; Bricalli, D; Clerici, M; Dally, LG; Di Fabio, S; Ferrante, P; Pirillo, M; Principi, N; Saresella, M; Vanzulli, A; Vella, S; Vigano, A	1
Bilello, JA; D'Argenio, DZ; Drusano, GL; Snyder, S; Weislow, O	1
Aizawa, S; Aoki, M; Ida, S; Kikuchi, Y; Oka, S; Sakai-Hachiya, A; Tachikawa, N; Yasuoka, A	1
Borowski, L; Day, RB; Fan, Z; Hildebrand, WH; Hoji, A; Huang, XL; Kalinyak, C; Margolick, JB; McMahon, DK; Mellors, JW; Riddler, SA; Rinaldo, CR	1
Bellet, H; Bessis, D; Brunel, M; Callis, A; Faucherre, V; Guilhou, JJ; Vallat, C	1
Butler, KM; Clarke, SM; Condon, S; Healy, CM; Mulcahy, F	1
Casado, JL; Moreno, S	1
Tovo, PA	1
Allende, MC; Belloso, WH; Benetucci, JA; Cahn, PE; Davey, RT; Emery, S; Lane, HC; Lasala, MC; Law, MG; Lopardo, G; Losso, MH; Nelson, E; Salomon, H; Saracco, M	1
Adachi, T; Hoshino, H; Matsuoka, S; Mizoi, Y; Takagi, M	1
Agnoli, M; Al-Harthi, L; Landay, A; Pottage, J; Siegel, J; Spritzler, J	1
Carrington, M; Havlir, DV; Ioannidis, JP; McDermott, DH; Murphy, PM; O'Brien, TR; Richman, DD	1
Burger, DM; de Graeff-Meeder, ER; De Groot, R; Geelen, SP; Hartwig, NG; Hop, WC; Niesters, HG; Osterhaus, AD; Scherpbier, HJ; Slieker, WA; Suur, MH; van Rossum, AM; Veerman, AJ; Weemaes, CM	1
Antinori, S; Clerici, M; Galli, M; Gervasoni, C; Pizzuto, M; Ridolfo, AL; Santambrogio, S; Trabattoni, D	1
Boschini, A; Calista, D	1
Avilés, A; Halabe, J	1
Aladdin, H; Dickmeiss, E; Gerstoft, J; Hede, A; Jørgensen, LB; Katzenstein, TL; Nielsen, C; Nielsen, H	1
Chodakewitz, JA; Condra, JH; Emini, EA; Eron, JJ; Gonzalez, C; Gulick, RM; Havlir, D; Isaacs, R; Jonas, L; McMahon, D; Meibohm, A; Mellors, JW; Richman, DD; Valentine, FT	1
Carr, A; Chuah, J; Cooper, DA; Emery, S; French, M; Hoy, J; Hudson, J; Law, M; Sayer, D	1
Bergmann, F; Carls, H; Fätkenheuer, G; Fenske, S; Knechten, H; Nadler, M; Oette, M; Rieke, A; Rockstroh, JK; Thiesen, A; Wiesel, W	1
Burger, DM; Hoetelmans, RM; Jurriaans, S; Lange, JM; Portegies, P; Prins, JM; Sommadossi, JP; Turner-Foisy, ML; van Praag, RM; Weverling, GJ; Zhou, XJ	1
Clayette, P; Dereuddre-Bosquet, N; Dormont, D; Jorajuria, S; Larghero, J; Le Grand, R; Neildez, O; Thiebot, H; Vaslin, B	1
Ahmed, PS; Bedard, J; Bowlin, TL; Chambers, P; Clarke, J; Kelly, LA; Rando, RF; Taylor, DL; Tyms, AS; Wood, LJ	1
Berrey, MM; Burckhardt, B; Clumeck, N; Cooper, DA; Corey, L; Lazzarin, A; Markowitz, M; Mehrotra, D; Perrin, L; Robertson, M; Smith, D; Weber, R	1
Bucy, RP; Gnann, JW; Goepfert, PA; Kilby, JM; Miller, AP; Saag, MS; Sillers, M	1
Collier, AC; Havlir, DV; Hirsch, MS; Ioannidis, JP; Richman, DD; Tebas, P	1
Acosta, EP; Bassett, RL; Bell, D; Eron, JJ; Fife, K; Johnson, VA; Kuritzkes, DR; Marschner, IC; Martinez, A; Murphy, RL; Pettinelli, CB; Sommadossi, JP; Wood, K	1
Clark, R; Cohen, C; Cooley, T; Grosso, R; Gulick, R; Marlowe, SI; Mauney, J; Mulanovich, V; Santana, J; Schoellkopf, N; Squires, KE; Stevens, M; Tebas, P; Uffelman, K; Wright, D; Yangco, B	1
Bellos, N; Eron, JJ; Esinhart, J; Grosso, R; Jemsek, J; Murphy, RL; Parenti, DM; Peterson, D; Pottage, J; Rashbaum, BC; Schoellkopf, N; Sepulveda, G; Stevens, M; Swindells, S	1
Behrens, GM; Meyer, D; Schmidt, RE; Stoll, M	1
Kennedy, I; Williams, S	1
Badia, X; Benavides, A; Coma, A; López Lavid, C; Pinto, JL	1
Arathoon, E; Benetucci, L; Cahn, P; Chodakewitz, J; Chung, MO; Collier, AC; Currier, J; de Jesus Pedro, R; Gallant, JE; Haas, DW; Harvey, C; Lewi, DS; Mehrotra, D; Nguyen, BY; Noriega, LM; Paar, D; Ramirez-Ronda, CH; Thompson, MA; Uip, DE; Uribe, P; White, AC	1
Chiodo, F; Fiacchi, P; Manfredi, R; Riolo, U	1
Pozo, F; Rivero, A; Serrano, R; Tenorio, A; Torre-Cisneros, J; Vidal, E	1
Bonfanti, P; Carradori, S; Faggion, I; Gabbuti, A; Iemoli, E; Landonio, S; Niero, F; Pusterla, L; Quirino, T; Ricci, E	1
Blaxhult, A; Rajs, J; Sundelin, B	1
Gallart, T; Garcia, F; Gatell, JM; Maleno, MJ; Miró, JM; Plana, M; Tortajada, C	1
Arnaiz, JA; Blanco, JL; Carné, X; Codina, C; Cruceta, A; García-Viejo, MA; Gatell, JM; Giner, V; Mallolas, J; Martínez, E; Pumarola, T; Sarasa, M; Soriano, A; Soy, D; Tuset, M	1
Ceballos-Garcia, L; Ceballos-Salobreña, A; Gaitán-Cepeda, LA; Lezama-Del Valle, D	1
Acosta, EP; Anderson, PL; Brundage, RC; Fletcher, CV; Henry, K; Kakuda, TN; Page, LM; Rhame, FS; Schacker, TW	1
Busch, M; Hecht, FM; Kahn, J; Levy, JA; Martinez-Marino, B; Ong, JC; Stranford, SA	1
Acosta, EP; Collier, AC; Havlir, DV; Hirsch, M; Richman, DD; Sommadossi, JP; Tebas, P; Zhou, XJ	1
Dworkin, MS; Wan, PT	1
Acosta, E; Currier, JS; D'Aquila, RT; Eron, JJ; Gerber, JG; Gulick, RM; Kuritzkes, DR; Murphy, RL; Smeaton, LM; Snyder, S; Sommadossi, JP; Tung, R	1
Collier, AC; Hirsch, MS; Hoering, A; Kuroda, MJ; Letvin, NL; Lifton, MA; Markee, J; McElrath, MJ; Sabath, DE; Schmitz, JE; Seth, A; Sevin, A	1
Bottasso, OA; Giovannoni, AG; Luraghi, MR; Montero, A; Sen, L	1
Abbate, I; Antonelli, G; Capobianchi, MR; D'Offizi, G; Dianzani, F; Galati, V; Pandolfi, F; Pierdominici, M; Turriziani, O	1
Albuzza, M; Amorico, G; Bedini, A; Esposito, R; Guaraldi, G; Orlando, G; Ventura, P	1
Iwata, M; Ota, K; Shimizu, Y; Takeuchi, M; Yogo, Y	1
Citterio, P; De Pasquale, MP; Galli, M; Kurtagic, S; La Seta Catamancio, S; Rusconi, S	1
Achilli, G; Bruno, R; Debiaggi, M; Filice, G; Patruno, SF; Pistorio, A; Romero, E; Sacchi, P; Zara, F	1
Brotas, V; Cooper, D; Cutrell, A; Gathe, J; Hammer, SM; Hetherington, S; Hicks, C; Isaacs, R; Johnson, M; Keiser, P; Montaner, J; Raffi, F; Spreen, W; Staszewski, S; Steel, H; Thorborn, D; Tortell, S	1
Jankelevich, S; Mackall, CL; Mueller, BU; Nelson, RP; Nguyen, BY; Pizzo, PA; Serchuck, L; Sleasman, JW; Smith, S; Steinberg, SM; Wood, LV; Yarchoan, R; Zeichner, SL; Zwerski, S	1
Belfort, R; Castelo, A; Martins, SA; Muccioli, C	1
Arazo, P; Manero, FJ; Sesma, J	1
Brown, AJ; Emini, E; Eron, J; Fiscus, S; Frost, SD; Gamagami, R; Gulick, R; Günthard, HF; Haase, A; Havlir, DV; Ignacio, CC; Isaacs, R; Jonas, L; Meibohm, A; Mellors, J; Richman, DD; Schleif, W; Valentine, F; Wong, JK; Zhang, ZQ	1
Ambinder, R; Flexner, C; Grochow, L; Hamzeh, F; Harrington, W; Herndier, B; Kaplan, L; Lee, J; Levine, A; Ratner, L; Redden, D; Scadden, D; Straus, D; Tan, B; Tang, S	1
Achilli, G; Bruno, R; De Santolo, A; Debiaggi, M; Filice, G; Maserati, R; Pistorio, A; Romero, E; Sacchi, P; Spinillo, A; Zara, F	1
Ahrlund-Richter, L; Britton, S; Larsson, S; Maijgren-Steffensson, C; Sönnerborg, A; Vahlne, A	1
Kessler, HA; Nerad, JL	1
Laurence, J	1
Mascolini, M	2
Gilden, D	2
Levin, J	1
Chang, HE	1
Smart, T	2
James, JS	1
Randall, P	1
Woodward, J	1
Zuger, A	1
Baker, R	1
Bowersox, J	1
Asjö, B; Berg, OG; Dyrhol-Riise, AM; Kleivbo, S; Olofsson, J; Voltersvik, P	1
Gellett, LR; Haddon, L; Maskell, GF	1
Funk, MB; Klingebiel, T; Kreuz, W; Linde, R; Notheis, G; Schuster, T; Wintergerst, U	1
Burger, DM; de Wolf, F; Foudraine, NA; Hoetelmans, RM; Jurriaans, S; Lange, JM; Maas, J; Miedema, F; Portegies, P; Reiss, P; Roos, MT; Weverling, GJ	1
Chougnet, C; Fowke, K; Jankelevich, S; Liewehr, D; Mueller, BU; Pizzo, PA; Shearer, GM; Steinberg, SM; Yarchoan, R	1
Bassett, R; Collier, AC; Condra, J; Gilbert, P; Günthard, HF; Havlir, DV; Hirsch, MS; Ignacio, C; Levitan, D; Richman, DD; Tebas, P; Wong, JK	1
Holodniy, M; Mole, L; Schmidgall, D	1
Adams, EM; Bennett, K; Collier, AC; Gilbert, PB; Goodwin, D; Havlir, DV; Hirsch, MS; Holohan, MK; Richman, DD; Schnittman, S; Tebas, P; Wheat, LJ	1
Bartlett, JG; del Rio, C	1
Haase, CP; Hoit, BD; Lewis, W; Raidel, SM; Russ, RB; Samarel, AM; Sutliff, RL	1
Bosch, RJ; Coombs, RW; Demeter, LM; Fischl, MA; Fiscus, SA; Grimes, JM; Hammer, SM; Hughes, MD; Jackson, JB; Spector, SA; Squires, KE	1
Belson, M; Chun, TW; Connors, M; Davey, RT; Dybul, M; Fauci, AS; Hallahan, CW; Herpin, B; Hidalgo, B; Justement, JS; Metcalf, JA; Migueles, SA; Perry, C	1
Appay, V; Furtado, M; Hansasuta, P; Havlir, DV; McMichael, AJ; Richman, DD; Rowland-Jones, SL; Schrier, RD; Spina, CA; Sutton, J; Wolinsky, SM; Wong, JK	1
Craig, K	1
Bettendorf, D; Bucy, RP; Chan, E; Evans, T; Gonzalez, CJ; Landay, AL; Phair, JP; Schmitz, JL; Schnizlein-Bick, CT; Spritzler, J; Squires, KE	1
Anderson, PL; Brundage, RC; Fletcher, CV; Gross, CR; Henry, K; Kakuda, TN; Schacker, TW	1
Aboulker, JP; Brun Vezinet, F; Calvez, V; Descamps, D; Flandre, P; Harel, M; Hazebrouck, S; Meiffredy, V; Peytavin, G; Pialoux, G; Raffi, F	1
Burger, DM; de Groot, R; Geelen, SP; Hartwig, NG; Hop, WC; Osterhaus, AD; Scherpbier, HJ; Schutten, M; van Lochem, EG; van Rossum, AM; Weemaes, CM; Wolfs, TF	1
Cai, W; Cao, Y; Ding, Y; Gao, M; Li, L; Mei, S; Zhang, F	1
Stekelenburg, J	1
Baldovino, S; Chiapello, N; Mostert, M; Piccinini, M; Ricotti, E; Rinaudo, MT; Tovo, PA	1
de Wolf, F; Jurriaans, S; Lange, JM; Prins, JM; van Praag, RM; Wit, FW	1
Aboulker, JP; Brun-Vezinet, F; Certain, A; Descamps, D; Flandre, P; Gastaut, JA; Goujard, C; Joly, V; Meiffredy, V; Remy, G; Ruffault, A; Yeni, P	1
Di Perri, G; Maiello, A; Quario, M; Racca, D; Sinicco, A; Zeme, DA	1
Aukrust, P; Frøland, SS; Kvale, D; Mellbye, OJ; Müller, F; Nordøy, I; Tjønnfjord, GE	1
Chotmongkol, V; Pesee, M	1
Brunet, C; Costello, RT; Dignat-George, F; Gastaut, JA; Olive, D; Sampol, J	1
Brun-Vézinet, F; Delagnes, M; Descamps, D; Flandre, P; Meiffredy, V; Peytavin, G; Raffi, F; Saidi, Y	1
Aboulker, JP; Certain, A; Flandre, P; Gérard, L; Guiramand-Hugon, S; Jacomet, C; Joly, V; Launay, O; Lévy, C; Morand-Joubert, L; Peytavin, G; Rivet, S; Yéni, P	1
Anderson, ML; Kawanishi, H; Shah, N; Vasseur, BG	1
Blanche, S; Bodemer, C; Brousse, N; Fardet, L; Fraitag, S	1
Aboulker, JP; Flandre, P; Harel, M; Joly, V; Leturque, N; Meiffredy, V; Yeni, P	1
Aboulker, JP; Brun-Vézinet, F; Descamps, D; Flandre, P; Harel, M; Izopet, J; Joly, V; Lastère, S; Meiffrédy, V; Peytavin, G; Tamalet, C; Yéni, P; Zeng, AF	1
Aggarwal, V; Hakim, A; Pai-Dhungat, JV; Parikh, F; Satija, P; Sharma, B	1
Antunes, F; Bánhegyi, D; Clotet, B; Clumeck, N; Gatell, J; Gonzalez-Lahoz, J; Gulick, R; Horban, A; Johnson, VA; Katlama, C; Lange, JM; Montaner, J; Moroni, M; Murphy, RL; Pavia, AT; Reiss, P; Schmidt, RE; Sommadossi, JP; Squires, K; Staszewski, S; van der Valk, M; van Eeden, A; van Leeuwen, R; van Leth, F; van Weert, L	1
Brault, C; Chennebault, JM; Loison, J; Payan, C; Peigne, M	1
Singh, G	1
Bailey, VL; Bowles, FB; Finn, TS; Haas, DW; Harris, VL; Johnson, B; Nicotera, J; Raffanti, S; Saah, AJ; Schranz, J; Stone, J	1
Bachiller Luque, P; de Luis Román, DA; Eiros Bouza, JM; Ortega Lafont, M; Ortiz de Lejarazu, R	1
Korman, TM; Tapley, N; Woolley, I	1
Chen, J; DiNubile, MJ; Fischl, MA; Harvey, CM; Hirsch, MS; Hirschel, B; Leavitt, RY; McMahon, D; Squires, K; Staszewski, S; Steigbigel, RT	1
Chodakewitz, JA; Eron, JJ; Gonzalez, C; Gulick, RM; Havlir, D; Isaacs, R; McMahon, D; Meibohm, A; Mellors, JW; Mosley, A; Richman, DD; Robertson, M	1
Bonard, D; Dabis, F; Ekouévi, DK; Huet, C; Minga, A; Rouet, F; Rouzioux, C; Salamon, R; Toni, TA	1
Danner, SA; Gruzdev, B; Jurriaans, S; Lange, JM; Peeters, M; Prins, JM; Rakhmanova, A; Sankatsing, SU; van't Klooster, G; Weverling, GJ	1
Agher, R; Ait-Mohand, H; Bricaire, F; Calvez, V; Costagliola, D; Duvivier, C; Ghosn, J; Katlama, C; Marcelin, AG; Myrto, A; Peytavin, G; Schneider, L	1
Bosch, RJ; Demeter, LM; Dykes, C; Furtado, M; Hammer, SM; Hart, S; Najjar, J; Wantman, M	1
McComsey, GA; Piliero, PJ	1
Cahn, P; Carosi, G; Jordan, JC; Montroni, M; Pearce, G; Pharo, CE; Schechter, M; Smaill, F; Soto-Ramirez, L; Thomas, NE; Vibhagool, A	1
Cahn, P; Carosi, G; Jordan, JC; Pharo, CE; Schechter, M; Smaill, F; Soto-Ramirez, L; Steel, HM; Thomas, NE; Vibhagool, A	1
Carides, GW; Cook, JR; Coplan, PM; DiNubile, MJ; Hammer, SM; Heyse, JF; Meibohm, AR; Nguyen, BY; Wu, AW	1
Demeter, LM; Erice, A; Eshleman, SH; Fischl, MA; Hammer, SM; Hellmann, NS; Ribaudo, HJ	1
Cauda, R; Cingolani, A; De Luca, A; Di Giambenedetto, S; Marzocchetti, A; Pompucci, A; Scoppettuolo, G; Tumbarello, M; Vago, G	1
Aboulker, JP; Gérard, L; Guiramand-Hugon, S; Launay, O; Marcellin, F; Morand-Joubert, L; Yeni, P	1
Bedoni, AJ; Figueiredo, RM; Garcia, MT; Moretti, ML; Papaiordanou, PM; Resende, MR	1
Cook, JE; Dasgupta, S; Gorry, PR; Middaugh, LD; Terry, EC; Tyor, WR; Wesselingh, SL	1
Boyd, M; Bunyaprawit, P; Burger, D; Chuenyam, T; Cooper, D; Horsakulchai, M; Lange, J; Mahanontharit, A; Mootsikapun, P; Phanuphak, P; Ruxrungtham, K; Sangkote, J; Ubolyam, S	1
Amel, EB; Amel, LO; Amine, SM; Asma, J; Fethi, T; Mohamed, C; Mounira, G; Taoufik, BC	1
Anunnatsiri, S; Boonyaprawit, P; Chetchotisakd, P; Mootsikapun, P	1
Heil, M; Jones, J; Kutsch, O; Ochsenbauer-Jambor, C; Zammit, KP	1
Barberá Farré, JR; Beato Pérez, JL; Cuadra García-Tenorio, F; Geijo Martínez, MP; Maciá Martínez, MA; Marcos Sánchez, F; Martínez Alfaro, E; Moreno Mendaña, JM; Rodríguez Zapata, M; Sanz Moreno, J; Sanz Sanz, J; Solera Santos, J	1
de Baar, MP; de Ronde, A; Ruiter, JP; Tebas, P; Timmermans, EC; Wanders, RJ	1
Boyd, MA; Burger, DM; Cooper, DA; Duncombe, CJ; Hassink, EA; Khongphattanayothin, M; Lange, J; Phanuphak, P; Reiss, P; Ruxrungtham, K; Srasuebkul, P; Stek, M; Ubolyam, S	1
Anderson, PL; Aquilante, CL; Fletcher, CV; Lamba, J; Schuetz, E	1
Aleksoniene, R; Ambrozaitis, A; Matulionyte, R; Paulauskiene, R	1
Certain, A; Clavel, F; Costagliola, D; Dalban, C; Descamps, D; Duval, X; Launay, O; Mouajjah, S; Peytavin, G; Ralaimazava, P; Verdon, R	1
Cimerman, S; Diaz, RS; Lewi, DS; Sucupira, MC	1
Anastos, K; Cohen, M; Cole, S; Hessol, NA; Justman, J; Kaplan, RC; Lu, D; Shi, Q; Tien, PC; Vigen, C; Young, M	1
Diquet, B; Goujard, C; Legrand, M; Mentré, F; Panhard, X; Taburet, AM	1
Altinbaş, A; Büyükaşik, Y; Ozkaya, G; Unal, S	1
Doerries, R; Drechsler, H; Gass, A; Hardmeier, M; Kuhle, J; Mehling, M; Ruegg, S	1
Cucoranu, I; Fields, E; Green, E; Hosseini, SH; Hoying-Brandt, A; Ivey, K; Johnson, D; Kohler, JJ; Lewis, W; Raper, CM; Russ, R; Santoianni, R; Srivastava, J; Wittich, B	1
Benech, H; Bourry, O; Brochard, P; Calvo, J; Dereudre-Bosquet, N; Kazanji, M; Le Grand, R; Makuwa, M; Martinon, F; Souquiere, S	1
Moreno, V; Valencia, ME	1
Lu, K; Mehrotra, DV	1
Benech, H; Bourry, O; Dereuddre-Bosquet, N; Durand-Gasselin, L; Le Grand, R; Mannioui, A; Roques, P; Roucairol, C; Sellier, P	1
Calis, JC; de Wit, TF; Geelen, SP; Sigaloff, KC; van Vugt, M	1
Bourry, O; Brown, C; Dejucq-Rainsford, N; Deleage, C; Denis, H; Deureuddre-Bosquet, N; Le Grand, R; Le Tortorec, A; Moreau, M; Roques, P; Satie, AP	1
Guo, D; Huang, J; Li, Q; Polli, JE; Shu, Y; Yang, H; Ye, Z; Zhang, W; Zhu, P	1
Ekins, S; Williams, AJ; Xu, JJ	1

Reviews

15 review(s) available for lamivudine and indinavir sulfate

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Antiretroviral therapy: a guide to the most important trials. Schweizerische medizinische Wochenschrift, 1997, Mar-15, Volume: 127, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Viral Load; Zalcitabine; Zidovudine	1997
Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients: Part 2. Genitourinary medicine, 1997, Volume: 73, Issue:1 Topics: Adolescent; Adult; Anti-HIV Agents; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Ritonavir; Saquinavir	1997
Antiviral chemotherapy. Current opinion in pediatrics, 1997, Volume: 9, Issue:2 Topics: Adult; Antiviral Agents; Child; HIV Infections; Humans; Indinavir; Lamivudine; Nevirapine; Protease Inhibitors; Pyridines; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Stavudine	1997
Platelet dysfunction as the cause of spontaneous bleeding in two haemophilic patients taking HIV protease inhibitors. Thrombosis and haemostasis, 1998, Volume: 79, Issue:6 Topics: Adolescent; Adult; Anti-HIV Agents; Hemophilia A; Hemorrhage; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine	1998
[Antiretroviral treatment in human immunodeficiency virus infection]. Annales de dermatologie et de venereologie, 1997, Volume: 124, Issue:9 Topics: Antiviral Agents; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Ritonavir; Saquinavir; Stavudine; Treatment Outcome; Viral Load; Zalcitabine; Zidovudine	1997
Antiretroviral chemotherapy. Current clinical topics in infectious diseases, 1998, Volume: 18 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Delavirdine; Didanosine; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Oxazines; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine	1998
Toxicity of antiretroviral agents. The American journal of medicine, 1997, May-19, Volume: 102, Issue:5B Topics: Anti-HIV Agents; Didanosine; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Occupational Exposure; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine	1997
Prevalence and incidence of resistance to zidovudine and other antiretroviral drugs. The American journal of medicine, 1997, May-19, Volume: 102, Issue:5B Topics: Anti-HIV Agents; Drug Resistance, Microbial; HIV Protease Inhibitors; HIV-1; Humans; Incidence; Indinavir; Lamivudine; Prevalence; Reverse Transcriptase Inhibitors; Risk Factors; Saquinavir; Stavudine; Time Factors; Zidovudine	1997
Antiretrovirals. Mayo Clinic proceedings, 1999, Volume: 74, Issue:12 Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; Cyclopropanes; Delavirdine; Didanosine; Dideoxynucleosides; Female; Furans; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Oxazines; Pregnancy; Pregnancy Complications, Infectious; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Stavudine; Sulfonamides; Zalcitabine; Zidovudine	1999
Review of NNRTIs: 'today and tomorrow'. International journal of clinical practice. Supplement, 1999, Volume: 103 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Reverse Transcriptase Inhibitors; Zidovudine	1999
Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report. Annals of internal medicine, 2000, Sep-19, Volume: 133, Issue:6 Topics: Acute Disease; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Chronic Disease; Disease Progression; Drug Therapy, Combination; Fever; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Recurrence; Reverse Transcriptase Inhibitors; RNA, Viral; Syndrome; Viral Load; Zidovudine	2000
Occupational exposure to HIV and post-exposure prophylaxis in healthcare workers. Occupational medicine (Oxford, England), 2000, Volume: 50, Issue:6 Topics: Anti-HIV Agents; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Exposure; Reverse Transcriptase Inhibitors; United Kingdom; Zidovudine	2000
Cutaneous EBV-related lymphoproliferative disorder in a 15-year-old boy with AIDS: an unusual clinical presentation. Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Antigens, CD; Antiretroviral Therapy, Highly Active; Combined Modality Therapy; Diagnosis, Differential; Epstein-Barr Virus Infections; Gene Rearrangement, T-Lymphocyte; Herpesvirus 4, Human; HIV Protease Inhibitors; Humans; Immunophenotyping; Indinavir; Lamivudine; Lymphoma, AIDS-Related; Lymphoma, T-Cell, Cutaneous; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Sarcoma, Kaposi; Skin Neoplasms; Stavudine; Transfusion Reaction; Viral Matrix Proteins	2002
HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review. The Lancet. Infectious diseases, 2011, Volume: 11, Issue:10 Topics: Adolescent; Africa; Alkynes; Anti-HIV Agents; Asia; Benzoxazines; Child; Child, Preschool; Cross-Sectional Studies; Cyclopropanes; Developing Countries; Drug Resistance, Viral; Female; Health Resources; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Latin America; Lopinavir; Male; Mutation; Nevirapine; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Treatment Failure; Viral Load; Zidovudine	2011

Trials

97 trial(s) available for lamivudine and indinavir sulfate

Article	Year
Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet (London, England), 1997, May-17, Volume: 349, Issue:9063 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Prospective Studies; Saquinavir; Zidovudine	1997
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. The New England journal of medicine, 1997, Sep-11, Volume: 337, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Zidovudine	1997
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. The New England journal of medicine, 1997, Sep-11, Volume: 337, Issue:11 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; RNA, Viral; Viral Load; Zidovudine	1997
Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience. AIDS (London, England), 1997, Volume: 11, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Indinavir; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pilot Projects; Retrospective Studies; Stavudine; Zidovudine	1997
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proceedings of the National Academy of Sciences of the United States of America, 1997, Nov-11, Volume: 94, Issue:23 Topics: Anti-HIV Agents; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Lymph Nodes; RNA, Viral; Viral Load; Zidovudine	1997
Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay. Journal of medical virology, 1998, Volume: 54, Issue:1 Topics: Adult; Anti-HIV Agents; Colorimetry; Didanosine; DNA, Viral; Evaluation Studies as Topic; Female; HIV-1; Humans; Indinavir; Lamivudine; Male; Polymerase Chain Reaction; Proviruses; Ritonavir; RNA, Viral; Transcription, Genetic; Zalcitabine; Zidovudine	1998
Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. Journal of virology, 1998, Volume: 72, Issue:3 Topics: Amino Acid Sequence; Base Sequence; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Genotype; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Lymph Nodes; Molecular Sequence Data; Mutation; RNA, Viral; Viral Load; Virus Replication; Zidovudine	1998
A pilot study of nevirapine, indinavir, and lamivudine among patients with advanced human immunodeficiency virus disease who have had failure of combination nucleoside therapy. The Journal of infectious diseases, 1998, Volume: 177, Issue:6 Topics: Anti-HIV Agents; Consumer Product Safety; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Nevirapine; Nucleosides; Pilot Projects; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Failure; Viral Load	1998
A phase I/II study of the protease inhibitor indinavir in children with HIV infection. Pediatrics, 1998, Volume: 102, Issue:1 Pt 1 Topics: Adolescent; Adult; Biological Availability; Capsules; CD4 Lymphocyte Count; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infant; Lamivudine; Male; Suspensions; Viral Load; Virus Replication; Zidovudine	1998
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up. JAMA, 1998, Jul-01, Volume: 280, Issue:1 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Viral Load; Zidovudine	1998
An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine. AIDS (London, England), 1998, Aug-20, Volume: 12, Issue:12 Topics: Adult; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Homosexuality, Male; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Stavudine; Treatment Outcome; Viral Load; Zidovudine	1998
Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team. The New England journal of medicine, 1998, 10-29, Volume: 339, Issue:18 Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Multivariate Analysis; Remission Induction; RNA, Viral; Treatment Failure; Viral Load; Zidovudine	1998
A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team. The New England journal of medicine, 1998, Oct-29, Volume: 339, Issue:18 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Remission Induction; RNA, Viral; Treatment Failure; Viral Load; Zidovudine	1998
Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells. Antiviral research, 1998, Volume: 39, Issue:3 Topics: Anti-HIV Agents; Antigens, CD; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Flow Cytometry; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunologic Memory; Immunophenotyping; Indinavir; Lamivudine; Lymphocyte Activation; Statistics, Nonparametric; T-Lymphocyte Subsets; Viral Load; Zidovudine	1998
Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. The Journal of infectious diseases, 1999, Volume: 179, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antigens, Bacterial; CD4-Positive T-Lymphocytes; Cell Division; Chemokines; Cytokines; Double-Blind Method; Female; HIV Antigens; HIV-1; Humans; Indinavir; Lamivudine; Male; Mitogens; RNA, Viral; Viremia; Zidovudine	1999
[Increased serum level of naive CD8+-T-cells during intensive antiretroviral therapy]. Nederlands tijdschrift voor geneeskunde, 1998, Oct-03, Volume: 142, Issue:40 Topics: Antiviral Agents; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Lamivudine; Lymphocyte Count; Male; Saquinavir; Zidovudine	1998
Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations. AIDS (London, England), 1999, Feb-25, Volume: 13, Issue:3 Topics: CD4 Lymphocyte Count; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Mutation; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Viral Load; Zidovudine	1999
[Experiences with antiretroviral combination therapy]. Ugeskrift for laeger, 1999, Mar-22, Volume: 161, Issue:12 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; N-Glycosyl Hydrolases; Retrospective Studies; Ritonavir; RNA, Viral; Zidovudine	1999
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study). AIDS (London, England), 1999, May-07, Volume: 13, Issue:7 Topics: Adult; Anti-HIV Agents; Capsules; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Gelatin; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Treatment Outcome; Zidovudine	1999
Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. The Journal of infectious diseases, 1999, Volume: 180, Issue:2 Topics: Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; DNA, Viral; Drug Therapy, Combination; HIV Antibodies; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Prospective Studies; RNA, Viral; T-Lymphocyte Subsets; Viremia; Zidovudine	1999
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. AIDS (London, England), 1999, Apr-16, Volume: 13, Issue:6 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine	1999
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy. The Journal of infectious diseases, 1999, Volume: 180, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Survival Rate; Zidovudine	1999
Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy. The Journal of infectious diseases, 1999, Volume: 180, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Viral Load; Zidovudine	1999
Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytes in asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1 immunogen. AIDS (London, England), 1999, Sep-10, Volume: 13, Issue:13 Topics: AIDS Vaccines; Anti-HIV Agents; CD4 Lymphocyte Count; Combined Modality Therapy; DNA, Viral; Drug Therapy, Combination; Freund's Adjuvant; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Monocytes; Pilot Projects; RNA, Viral; T-Lymphocytes, Helper-Inducer; Viral Load; Zidovudine	1999
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. The New England journal of medicine, 1999, Dec-16, Volume: 341, Issue:25 Topics: Adult; Alkynes; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine	1999
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood, 2000, Jan-01, Volume: 95, Issue:1 Topics: Anti-HIV Agents; Antigens, CD; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; HIV Infections; HIV Seronegativity; HIV-1; Humans; Indinavir; Ki-67 Antigen; Lamivudine; Longitudinal Studies; Lymphocyte Activation; RNA, Viral; Saquinavir; T-Lymphocyte Subsets; T-Lymphocytes; Viral Load; Zidovudine	2000
Update on study 006--EFV + AZT + 3TC versus the current 'standard of care' IDV + AZT + 3TC. International journal of clinical practice. Supplement, 1999, Volume: 103 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Humans; Indinavir; Lamivudine; Lipid Metabolism; Oxazines; Viral Load; Zidovudine	1999
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team). JAMA, 2000, Jan-12, Volume: 283, Issue:2 Topics: Anti-HIV Agents; Case-Control Studies; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Patient Compliance; Treatment Failure; Viral Load; Zidovudine	2000
Indinavir pharmacokinetics and parmacodynamics in children with human immunodeficiency virus infection. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:3 Topics: Adolescent; Anti-HIV Agents; Area Under Curve; Body Surface Area; CD4 Lymphocyte Count; Child; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Stavudine; Viral Load	2000
A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients. AIDS (London, England), 2000, Jan-28, Volume: 14, Issue:2 Topics: Adult; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Kidney Diseases; Lamivudine; Male; Nelfinavir; Patient Compliance; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome	2000
AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients. AIDS (London, England), 2000, Mar-10, Volume: 14, Issue:4 Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Patient Compliance; Placebos; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine	2000
A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3. The Journal of infectious diseases, 2000, Volume: 181, Issue:5 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Didanosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Injections, Subcutaneous; Interleukin-2; Lamivudine; Lymphocyte Count; Male; Nelfinavir; Nevirapine; Ritonavir; RNA, Viral; Saquinavir; Stavudine; Zalcitabine; Zidovudine	2000
Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. AIDS (London, England), 2000, May-05, Volume: 14, Issue:7 Topics: Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cytokines; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load; Virus Replication; Zidovudine	2000
Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy. AIDS (London, England), 2000, May-05, Volume: 14, Issue:7 Topics: Adult; Alleles; Anti-HIV Agents; Chemokine CXCL12; Chemokines, CXC; Drug Therapy, Combination; Female; Gene Frequency; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Linkage Disequilibrium; Male; Polymorphism, Genetic; Receptors, CCR2; Receptors, CCR5; Receptors, Chemokine; Receptors, Cytokine; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zidovudine	2000
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV The Journal of pediatrics, 2000, Volume: 136, Issue:6 Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Infant; Lamivudine; Male; Netherlands; Prospective Studies; Zidovudine	2000
Improved prognosis in patients with acquired immunodeficiency syndrome-related lymphoma. Cancer biotherapy & radiopharmaceuticals, 1999, Volume: 14, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lymphoma, AIDS-Related; Male; Middle Aged; Mitoxantrone; Prognosis; Survival Rate; Vincristine; Zidovudine	1999
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine. Annals of internal medicine, 2000, Jul-04, Volume: 133, Issue:1 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Genotype; HIV; HIV Infections; Humans; Indinavir; Kidney Calculi; Lamivudine; Male; Middle Aged; RNA, Viral; Viral Load; Viremia; Zidovudine	2000
A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study. AIDS (London, England), 2000, Jun-16, Volume: 14, Issue:9 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Australia; CD4 Lymphocyte Count; Didanosine; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Stavudine; Viral Load; Zidovudine	2000
Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. German Ritonavir/Indinavir Study Group. AIDS (London, England), 2000, Jun-16, Volume: 14, Issue:9 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black People; CD4 Lymphocyte Count; Didanosine; Drug Administration Schedule; Female; Germany; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Stavudine; Time Factors; White People	2000
Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection. The Journal of infectious diseases, 2000, Volume: 182, Issue:3 Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Patient Compliance; Zidovudine	2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370. AIDS (London, England), 2000, Jul-28, Volume: 14, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Delavirdine; Female; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Viral Load; Zidovudine	2000
A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I). AIDS (London, England), 2000, Jul-28, Volume: 14, Issue:11 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thymidine; Zidovudine	2000
A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II). AIDS (London, England), 2000, Jul-28, Volume: 14, Issue:11 Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Didanosine; Dideoxynucleosides; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; Stavudine; Thymidine; Viral Load; Zidovudine	2000
Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine. AIDS (London, England), 2000, Sep-08, Volume: 14, Issue:13 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Administration Schedule; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Pilot Projects; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine	2000
Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin. AIDS (London, England), 2000, Sep-29, Volume: 14, Issue:14 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Daunorubicin; Didanosine; Drug Therapy, Combination; Herpesvirus 8, Human; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Stavudine; Viremia	2000
HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients. Antiviral therapy, 2000, Volume: 5, Issue:3 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chemoprevention; Female; Health Personnel; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zidovudine	2000
Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patients. Journal of acquired immune deficiency syndromes (1999), 2000, Nov-01, Volume: 25, Issue:3 Topics: Adult; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Pilot Projects; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load; Zidovudine	2000
Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:1 Topics: Adult; Algorithms; Anti-HIV Agents; Area Under Curve; Drug Therapy, Combination; Female; Half-Life; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Patient Compliance; Zidovudine	2001
Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients. AIDS (London, England), 2000, Dec-22, Volume: 14, Issue:18 Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zidovudine	2000
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373. The Journal of infectious diseases, 2001, Mar-01, Volume: 183, Issue:5 Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Furans; HIV Infections; Humans; Indinavir; Lamivudine; Male; Nevirapine; Odds Ratio; Prospective Studies; RNA, Viral; Safety; Stavudine; Sulfonamides; Time Factors; Treatment Outcome; Viral Load	2001
Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy. The Journal of infectious diseases, 2001, Mar-01, Volume: 183, Issue:5 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Dose-Response Relationship, Immunologic; Drug Therapy, Combination; Epitopes, T-Lymphocyte; Flow Cytometry; HIV Infections; HIV-1; HLA-DR Antigens; Humans; Immunodominant Epitopes; Immunohistochemistry; Immunophenotyping; Indinavir; Lamivudine; Leukocyte Common Antigens; Prospective Studies; Protein Tyrosine Phosphatase, Non-Receptor Type 1; T-Lymphocytes, Cytotoxic; Viral Load; Zidovudine	2001
Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial. JAMA, 2001, Mar-07, Volume: 285, Issue:9 Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Double-Blind Method; Drug Resistance, Microbial; Female; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; Humans; Indinavir; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Survival Analysis; Therapeutic Equivalency; Viral Load; Zidovudine	2001
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine. The Journal of infectious diseases, 2001, Apr-01, Volume: 183, Issue:7 Topics: Adolescent; Anti-HIV Agents; CD4 Antigens; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Leukocyte Common Antigens; Male; Protein Tyrosine Phosphatase, Non-Receptor Type 1; RNA, Viral; Viral Load; Zidovudine	2001
Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-15, Volume: 19, Issue:8 Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Indinavir; Lamivudine; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Stavudine; Treatment Outcome; Vincristine; Viral Load	2001
Combination shows reduction in viral levels. AIDS patient care and STDs, 1996, Volume: 10, Issue:3 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV; HIV Protease Inhibitors; HIV Seropositivity; Humans; Indinavir; Lamivudine; Time Factors; Zidovudine	1996
Sustiva combination effective as initial treatment. AIDS patient care and STDs, 1998, Volume: 12, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Indinavir; Lamivudine; Oxazines; Treatment Outcome	1998
Merck protease inhibitor trial seeks persons with CD4 count under 50. AIDS treatment news, 1995, Jun-16, Issue:no 225 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4 Lymphocyte Count; Drug Industry; Drug Therapy, Combination; HIV Protease Inhibitors; Hotlines; Humans; Indinavir; Lamivudine; Patient Selection; Pyridines; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine	1995
New protease inhibitor studies. Treatment review, 1995, Issue:no 18 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Pyridines; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine	1995
Treatment for primary infection. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:12 Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Cohort Studies; Controlled Clinical Trials as Topic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Placebos; Pyridines; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine	1995
Protease inhibitors: major study stopped when 3-drug arm proves superior. AIDS treatment news, 1997, Mar-07, Issue:No 266 Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Treatment Outcome; Zidovudine	1997
Low incidence of genotypic and phenotypic resistance in paediatric HIV-infected patients on long-term first-line antiretroviral triple therapy. AIDS (London, England), 2001, May-25, Volume: 15, Issue:8 Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Infant; Lamivudine; Male; Nelfinavir; Phenotype; Point Mutation; Reverse Transcriptase Inhibitors; Ritonavir; Time; Viral Load; Zidovudine	2001
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial. Antiviral therapy, 2001, Volume: 6, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; CD4 Lymphocyte Count; Drug Therapy, Combination; Follow-Up Studies; HIV-1; Humans; Indinavir; Lamivudine; Middle Aged; Prospective Studies; RNA, Viral; Zidovudine	2001
Long-term protease inhibitor-containing therapy results in limited improvement in T cell function but not restoration of interleukin-12 production in pediatric patients with AIDS. The Journal of infectious diseases, 2001, Jul-15, Volume: 184, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Antigens; HIV Protease Inhibitors; Humans; Indinavir; Interleukin-12; Lamivudine; Male; Phytohemagglutinins; T-Lymphocytes; Time Factors; Treatment Outcome; Viral Load; Zidovudine	2001
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression. AIDS (London, England), 2001, Jul-27, Volume: 15, Issue:11 Topics: Adolescent; Adult; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; Drug Therapy, Combination; Enzyme Inhibitors; Female; HIV Infections; Humans; Hydroxyurea; Indinavir; Lamivudine; Male; Nucleic Acid Synthesis Inhibitors; Pancreatitis; Prospective Studies; Survival Analysis; Treatment Failure; Viral Load; Zidovudine	2001
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320. Annals of internal medicine, 2001, Dec-04, Volume: 135, Issue:11 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Protocols; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Logistic Models; Male; Middle Aged; RNA, Viral; Viral Load; Zidovudine	2001
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection. The Journal of infectious diseases, 2002, Jan-01, Volume: 185, Issue:1 Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Coculture Techniques; Cyclopropanes; Drug Synergism; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Interferon-gamma; Interleukin-2; Lamivudine; Lymphocyte Activation; Lymphocyte Subsets; Oxazines; Pilot Projects; Reverse Transcriptase Inhibitors; Stavudine	2002
Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease. AIDS research and human retroviruses, 2002, Jan-20, Volume: 18, Issue:2 Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Antigens, CD; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cyclopropanes; Didanosine; Dideoxynucleosides; Double-Blind Method; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Outcome; Viral Load; Zidovudine	2002
Concentration-controlled compared with conventional antiretroviral therapy for HIV infection. AIDS (London, England), 2002, Mar-08, Volume: 16, Issue:4 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Feasibility Studies; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine	2002
Final analysis of the Trilège induction-maintenance trial: results at 18 months. AIDS (London, England), 2002, Mar-08, Volume: 16, Issue:4 Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Multivariate Analysis; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Zidovudine	2002
Results of 2 years of treatment with protease-inhibitor--containing antiretroviral therapy in dutch children infected with human immunodeficiency virus type 1. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Apr-01, Volume: 34, Issue:7 Topics: Adolescent; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Infant; Lamivudine; Male; Nelfinavir; Netherlands; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine	2002
[A clinical trial using zidovudine and lamivudine plus indinavir triple therapy in Chinese individuals with human immunodeficiency virus infection]. Zhonghua nei ke za zhi, 2002, Volume: 41, Issue:2 Topics: Adult; Aged; Anti-HIV Agents; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; China; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Count; Male; Middle Aged; RNA, Viral; Time Factors; Treatment Outcome; Viremia; Zidovudine	2002
Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir tria Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:6 Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Outcome; Viral Load; Zidovudine	2002
Anti-HIV agents. Indinavir--3 years and still going strong. TreatmentUpdate, 2000, Volume: 12, Issue:6 Topics: Adipose Tissue; Adult; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Viral Load; Zidovudine	2000
Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial. Antiviral therapy, 2002, Volume: 7, Issue:2 Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Patient Compliance; RNA, Viral; Treatment Outcome; Zidovudine	2002
Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Nov-01, Volume: 35, Issue:9 Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Nevirapine; Outcome Assessment, Health Care; Stavudine	2002
Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial. AIDS (London, England), 2002, Dec-06, Volume: 16, Issue:18 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Constitution; Body Mass Index; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Indinavir; Lamivudine; Male; Middle Aged; Risk Factors; Stavudine; Zidovudine	2002
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir. Journal of acquired immune deficiency syndromes (1999), 2002, Dec-15, Volume: 31, Issue:5 Topics: Anti-HIV Agents; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Mutation; Patient Compliance; RNA, Viral; Stavudine; Viral Load; Zidovudine	2002
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients. AIDS (London, England), 2003, May-02, Volume: 17, Issue:7 Topics: Adolescent; Adult; Aged; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Lipids; Male; Middle Aged; Nevirapine; Treatment Outcome	2003
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Adult; Anti-HIV Agents; Blood-Brain Barrier; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Immunoglobulin G; Indinavir; Lamivudine; Male; Middle Aged; Ritonavir; Stavudine	2003
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Oct-15, Volume: 37, Issue:8 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; RNA, Viral; Zidovudine	2003
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine. AIDS (London, England), 2003, Nov-07, Volume: 17, Issue:16 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine	2003
Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West Africa. Journal of acquired immune deficiency syndromes (1999), 2003, Nov-01, Volume: 34, Issue:3 Topics: Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Cote d'Ivoire; Drug Combinations; Enzyme-Linked Immunosorbent Assay; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Middle Aged; Prospective Studies; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Zidovudine	2003
TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen. AIDS (London, England), 2003, Dec-05, Volume: 17, Issue:18 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Nevirapine; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zidovudine	2003
Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudine. The Journal of infectious diseases, 2004, Mar-15, Volume: 189, Issue:6 Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Drug Resistance, Viral; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Mutation; RNA, Viral; Zidovudine	2004
Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014). Current medical research and opinion, 2004, Volume: 20, Issue:7 Topics: Adult; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Patient Compliance; Reverse Transcriptase Inhibitors; RNA; Surveys and Questionnaires; Therapeutic Equivalency; Treatment Outcome; Zidovudine	2004
Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine. Current medical research and opinion, 2004, Volume: 20, Issue:7 Topics: Adult; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Patient Compliance; Reverse Transcriptase Inhibitors; Risk Factors; Treatment Outcome; Zidovudine	2004
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Aug-01, Volume: 39, Issue:3 Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Quality of Life; Reverse Transcriptase Inhibitors; Sickness Impact Profile; Survival Analysis; Zidovudine	2004
HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Aug-15, Volume: 39, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Male; Nelfinavir; Phenotype; Stavudine; Treatment Failure; Zidovudine	2004
Contribution of cellular HIV-1 DNA quantification to the efficacy analysis of antiretroviral therapy: a randomized comparison of 2 regimens, including 3 drugs from 2 or 3 classes (TRIANON, ANRS 081). Journal of acquired immune deficiency syndromes (1999), 2005, Mar-01, Volume: 38, Issue:3 Topics: Adult; Anti-HIV Agents; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; Nevirapine; Proviruses; RNA, Viral; Stavudine; Treatment Outcome	2005
Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients. Antiviral therapy, 2005, Volume: 10, Issue:2 Topics: Administration, Oral; Adult; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Hospitals; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Thailand	2005
Effects on immunological and virological outcome of patients using one protease inhibitor or one non-nucleoside reverse transcriptase inhibitor in a triple antiretroviral therapy: normal clinical practice versus clinical trial findings. Current HIV research, 2005, Volume: 3, Issue:3 Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Oxazines; Retrospective Studies; Treatment Outcome; Tunisia; Viremia; Zidovudine	2005
Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes. Antiviral therapy, 2005, Volume: 10, Issue:8 Topics: Administration, Oral; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Indinavir; Lamivudine; Male; Ritonavir; RNA, Viral; Stavudine; Thailand; Treatment Outcome; Viral Load; Withholding Treatment	2005
[Clinical trial comparing efficacy and safety of four highly active antiretroviral therapy (HAART) in antiretroviral-naive treatment with advanced HIV infection]. Revista clinica espanola, 2006, Volume: 206, Issue:2 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Didanosine; Disease Progression; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Ritonavir; Stavudine; Zidovudine	2006
Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005). Antiviral therapy, 2006, Volume: 11, Issue:2 Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Ritonavir; RNA, Viral; Time Factors; Viral Load; Zidovudine	2006
Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study. Journal of acquired immune deficiency syndromes (1999), 2006, Aug-01, Volume: 42, Issue:4 Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Black People; Cytochrome P-450 CYP3A; DNA Primers; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Mitochondrial Proteins; Multidrug Resistance-Associated Proteins; Pharmacogenetics; Pilot Projects; Retrospective Studies; Ribosomal Proteins; Saccharomyces cerevisiae Proteins; Zidovudine	2006
Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109). Antiviral therapy, 2006, Volume: 11, Issue:7 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Resistance, Viral; Endpoint Determination; Female; France; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Pilot Projects; Ritonavir; Species Specificity; Viral Load	2006
Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART. European journal of clinical pharmacology, 2007, Volume: 63, Issue:11 Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Interactions; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Models, Biological; Nelfinavir; Reverse Transcriptase Inhibitors; Stavudine; Tissue Distribution; Zidovudine	2007

Other Studies

198 other study(ies) available for lamivudine and indinavir sulfate

Article	Year
The protease inhibitor ritonavir inhibits the functional activity of the multidrug resistance related-protein 1 (MRP-1). AIDS (London, England), 2002, Sep-06, Volume: 16, Issue:13 Topics: Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Etoposide; Flow Cytometry; HIV Protease Inhibitors; Humans; Multidrug Resistance-Associated Proteins; Probenecid; Reverse Transcriptase Inhibitors; Ritonavir; Tumor Cells, Cultured	2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
In vitro comparison of selected triple-drug combinations for suppression of HIV-1 replication: the Inter-Company Collaboration Protocol. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Volume: 10 Suppl 2 Topics: Antiviral Agents; Cell Line, Transformed; Cytopathogenic Effect, Viral; Didanosine; Drug Synergism; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Lamivudine; Nevirapine; Pyridines; Quinolines; Reverse Transcriptase Inhibitors; Saquinavir; Virus Replication; Zalcitabine; Zidovudine	1995
New drugs for HIV infection. The Medical letter on drugs and therapeutics, 1996, Apr-12, Volume: 38, Issue:972 Topics: Antiviral Agents; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Zalcitabine	1996
New guidelines set for occupational HIV exposure. Lancet (London, England), 1996, Jul-06, Volume: 348, Issue:9019 Topics: Accidents, Occupational; Antiviral Agents; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Practice Guidelines as Topic; Pyridines; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine	1996
HIV's Achilles' heel. Drugs and education are starting to slow the AIDS virus. Scientific American, 1996, Volume: 275, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Therapy, Combination; Health Education; Humans; Indinavir; Lamivudine; Pyridines; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine	1996
[HIV: less resistance due to combined treatment]. Deutsche medizinische Wochenschrift (1946), 1996, Dec-06, Volume: 121, Issue:49 Topics: Adult; Anti-HIV Agents; Computer Graphics; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Time Factors; Zidovudine	1996
HIV postexposure prophylaxis: new recommendations. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1997, Jan-15, Volume: 156, Issue:2 Topics: Anti-HIV Agents; Blood-Borne Pathogens; Chemoprevention; Drug Combinations; Guidelines as Topic; Health Personnel; HIV Infections; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Diseases; Zidovudine	1997
HIV trial stopped early after good results. BMJ (Clinical research ed.), 1997, Mar-08, Volume: 314, Issue:7082 Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Zidovudine	1997
Decline in deaths from AIDS due to new antiretrovirals. Lancet (London, England), 1997, May-03, Volume: 349, Issue:9061 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; British Columbia; CD4 Lymphocyte Count; Drug Therapy, Combination; Humans; Indinavir; Lamivudine; Mortality; Saquinavir; Stavudine	1997
Remission of progressive multifocal leucoencephalopathy after antiretroviral therapy. Lancet (London, England), 1997, May-24, Volume: 349, Issue:9064 Topics: Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Ataxia; Follow-Up Studies; Hemiplegia; Humans; Indinavir; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Male; Remission Induction; Stavudine	1997
Cure or control of HIV/AIDS? Medical hypotheses, 1997, Volume: 48, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Models, Biological; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine	1997
Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. AIDS (London, England), 1997, Volume: 11, Issue:10 Topics: Anti-HIV Agents; Central Nervous System; Dideoxynucleosides; Drug Therapy, Combination; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zidovudine	1997
Postexposure chemoprophylaxis for occupational exposure to HIV in the dental office. Journal of the American Dental Association (1939), 1997, Volume: 128, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Chemoprevention; Child; Dental Auxiliaries; Dentists; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Diseases; Occupational Exposure; Practice Guidelines as Topic; Risk Factors; United States; United States Public Health Service; Universal Precautions; Zidovudine	1997
[The management of the occupational exposures of health workers to HIV]. Atencion primaria, 1997, Jun-15, Volume: 20, Issue:1 Topics: Anti-HIV Agents; Drug Interactions; Drug Therapy, Combination; Health Personnel; HIV Infections; HIV-1; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Exposure; Saquinavir; Zidovudine	1997
Protease inhibitor therapy in children with perinatally acquired HIV infection. AIDS (London, England), 1997, Volume: 11, Issue:12 Topics: Anti-HIV Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Male; Protease Inhibitors; Retrospective Studies; Ritonavir; Saquinavir; Stavudine; Zidovudine	1997
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science (New York, N.Y.), 1997, Nov-14, Volume: 278, Issue:5341 Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Coculture Techniques; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Lymphocyte Activation; Mutation; RNA, Viral; T-Lymphocyte Subsets; Viral Load; Viremia; Virus Activation; Virus Latency; Virus Replication; Zidovudine	1997
[HIV-therapy: as early and as intensive as possible]. Deutsche medizinische Wochenschrift (1946), 1997, Oct-10, Volume: 122, Issue:41 Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Treatment Outcome; Zidovudine	1997
Drugs for HIV infection. The Medical letter on drugs and therapeutics, 1997, Dec-12, Volume: 39, Issue:1015 Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Delavirdine; Diarrhea; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Virus Replication; Zalcitabine; Zidovudine	1997
Safety and efficacy of two different triple drug combinations in which either lamivudine or didanosine were administered with stavudine plus indinavir. AIDS (London, England), 1997, Volume: 11, Issue:15 Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome	1997
Indinavir urinary stones as origin of upper urinary tract obstruction. Urologia internationalis, 1997, Volume: 59, Issue:4 Topics: Aged; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Ureteral Calculi; Ureteral Obstruction; Zidovudine	1997
HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir. AIDS (London, England), 1998, Jan-01, Volume: 12, Issue:1 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Monitoring; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Polymerase Chain Reaction; RNA, Viral; Zidovudine	1998
Paediatric AIDS--is now not the right time to act? South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1997, Volume: 87, Issue:10 Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine	1997
Effect of protease inhibitors on nucleoside analogue phosphorylation in vitro. British journal of clinical pharmacology, 1998, Volume: 45, Issue:2 Topics: Anti-HIV Agents; Cell Count; Cell Survival; Didanosine; Drug Interactions; Humans; Indinavir; Lamivudine; Leukocytes, Mononuclear; Nucleosides; Phosphorylation; Protease Inhibitors; Ritonavir; Saquinavir; Stavudine; Trypan Blue; Tumor Cells, Cultured; Zalcitabine; Zidovudine	1998
Drug shows potency against HIV. Dentistry today, 1996, Volume: 15, Issue:5 Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Zidovudine	1996
Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience. AIDS research and human retroviruses, 1998, May-01, Volume: 14, Issue:7 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Lymphocyte Activation; Lymphocyte Count; Middle Aged; Prospective Studies; Receptors, Antigen, T-Cell, alpha-beta; RNA, Viral; T-Lymphocyte Subsets; Viral Load; Zidovudine	1998
Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS (London, England), 1998, May-07, Volume: 12, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; Female; Herpesvirus 8, Human; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sarcoma, Kaposi; Stavudine; Treatment Outcome; Viral Load; Viremia; Zalcitabine; Zidovudine	1998
Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. AIDS (London, England), 1998, May-07, Volume: 12, Issue:7 Topics: Adult; Aged; Anti-HIV Agents; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Zidovudine	1998
Persistence of HIV-1 variants harbouring the zidovudine resistance mutation at pol codon 215 in patients who respond to triple combination therapy. AIDS (London, England), 1998, May-07, Volume: 12, Issue:7 Topics: Adult; Anti-HIV Agents; Codon; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genes, pol; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Mutation; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Virus Latency; Zidovudine	1998
Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy. AIDS (London, England), 1998, May-07, Volume: 12, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Therapy, Combination; Hepatitis C; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Necrosis; Red-Cell Aplasia, Pure; Reverse Transcriptase Inhibitors; Zidovudine	1998
Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs. AIDS (London, England), 1998, May-07, Volume: 12, Issue:7 Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cohort Studies; Drug Therapy, Combination; Hemophilia A; Hepacivirus; Hepatitis C; HIV; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Stavudine; Treatment Outcome; Viral Load; Zidovudine	1998
[HIV infection: DuPont Pharma presents the results of its antiretroviral agent]. Allergie et immunologie, 1998, Volume: 30, Issue:4 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Evaluation; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viremia; Zidovudine	1998
Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus. The Pediatric infectious disease journal, 1998, Volume: 17, Issue:6 Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infant; Lamivudine; Male; Reverse Transcriptase Inhibitors; Statistics, Nonparametric; Viral Load; Zidovudine	1998
Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Archives of internal medicine, 1998, Jul-13, Volume: 158, Issue:13 Topics: Anti-HIV Agents; Cost-Benefit Analysis; HIV Infections; Humans; Indinavir; Lamivudine; Occupational Exposure; United States; Zidovudine	1998
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America, 1998, Jul-21, Volume: 95, Issue:15 Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; DNA, Viral; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Virus Integration; Virus Latency; Virus Replication; Zidovudine	1998
Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy. AIDS (London, England), 1998, Jul-30, Volume: 12, Issue:11 Topics: Adult; Anti-HIV Agents; Data Interpretation, Statistical; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Virus Replication; Zidovudine	1998
Clinical experience with adding delavirdine to combination therapy in patients in whom multiple antiretroviral treatment including protease inhibitors has failed. AIDS (London, England), 1998, Jul-30, Volume: 12, Issue:11 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Delavirdine; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Failure; Viral Load; Zidovudine	1998
Occupational exposure to blood and body fluids: new postexposure prophylaxis recommendations. United States Occupational Safety and Health Administration. Journal of the California Dental Association, 1998, Volume: 26, Issue:4 Topics: Anti-HIV Agents; Blood-Borne Pathogens; Dental Staff; Dentistry; HIV Infections; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Mandatory Reporting; Occupational Exposure; Risk Factors; Risk Management; Surveys and Questionnaires; Zidovudine	1998
Chemoprophylaxis after occupational exposure to human immunodeficiency virus in forensic autopsy. Nihon hoigaku zasshi = The Japanese journal of legal medicine, 1998, Volume: 52, Issue:2 Topics: Anti-HIV Agents; Drug Therapy, Combination; Forensic Medicine; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Occupational Exposure; Zidovudine	1998
Neurological efficacy of stavudine, zidovudine, and lamivudine. Lancet (London, England), 1998, Aug-01, Volume: 352, Issue:9125 Topics: AIDS Dementia Complex; Anti-HIV Agents; Brain; Female; Follow-Up Studies; HIV-1; Humans; Indinavir; Lamivudine; Neopterin; RNA, Viral; Stavudine; Viral Load; Virus Replication; Zidovudine	1998
Resolution of severe Kaposi's sarcoma after initiation of antiretroviral triple therapy. European journal of medical research, 1998, Sep-17, Volume: 3, Issue:9 Topics: Adult; Anti-HIV Agents; Antibiotics, Antineoplastic; Doxorubicin; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Interferon-alpha; Lamivudine; Liposomes; Male; Remission Induction; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Stavudine	1998
Taste and smell complaints in HIV-infected patients. AIDS (London, England), 1998, Sep-10, Volume: 12, Issue:13 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Clarithromycin; Didanosine; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Quality of Life; Ritonavir; Smell; Surveys and Questionnaires; Taste; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine	1998
Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy. AIDS (London, England), 1998, Sep-10, Volume: 12, Issue:13 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Seropositivity; Humans; Indinavir; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Male; Viral Load; Zidovudine	1998
Cost of preventing HIV infection after sexual exposure. The Journal of family practice, 1998, Volume: 47, Issue:4 Topics: Anti-HIV Agents; Cost-Benefit Analysis; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Models, Theoretical; Reproducibility of Results; Sexual Behavior; Zidovudine	1998
Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. The Journal of infectious diseases, 1998, Volume: 178, Issue:4 Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; Atrophy; Brain; Female; Humans; Ibuprofen; Indinavir; Lamivudine; Magnetic Resonance Imaging; Neurons; Neurotoxins; Nitric Oxide; Quinolinic Acid; Toxicity Tests; Tumor Necrosis Factor-alpha; Zidovudine	1998
Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:5 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Liver Cirrhosis; Reverse Transcriptase Inhibitors; Stavudine	1998
Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Dec-15, Volume: 19, Issue:5 Topics: Adult; Amino Acid Sequence; Anti-HIV Agents; Base Sequence; CD4 Lymphocyte Count; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genes, pol; Genotype; Half-Life; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Leukocytes, Mononuclear; Longitudinal Studies; Male; Molecular Sequence Data; Mutation; Retrospective Studies; RNA, Viral; Zidovudine	1998
Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children. Highly active antiretroviral therapy. Lancet (London, England), 1998, Dec-12, Volume: 352, Issue:9144 Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Antigens, Differentiation; CD8-Positive T-Lymphocytes; Child; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Membrane Glycoproteins; NAD+ Nucleosidase; Stavudine; Viremia	1998
HIV-1 peripheral neuropathy and combination antiretroviral therapy. Lancet (London, England), 1998, Dec-12, Volume: 352, Issue:9144 Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nelfinavir; Nevirapine; Peripheral Nervous System Diseases; Saquinavir; Zidovudine	1998
Delayed occurrence of Graves' disease after immune restoration with HAART. Highly active antiretroviral therapy. Lancet (London, England), 1998, Dec-12, Volume: 352, Issue:9144 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Female; Graves Disease; Humans; Immunity; Indinavir; Lamivudine; Male; Ritonavir; Stavudine	1998
Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS (London, England), 1998, Dec-03, Volume: 12, Issue:17 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Female; Hepacivirus; Hepatitis C; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine	1998
Report updates recommendations for health workers exposed to HIV. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Sep-01, Volume: 55, Issue:17 Topics: Anti-HIV Agents; Drug Administration Schedule; Drug Therapy, Combination; Health Personnel; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Occupational Exposure; Practice Guidelines as Topic; United States; United States Public Health Service; Zidovudine	1998
Immunologic and virologic response of HIV-2 infection to antiretroviral therapy. AIDS (London, England), 1998, Dec-24, Volume: 12, Issue:18 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-2; Humans; Indinavir; Lamivudine; Male; Proviruses; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine	1998
Adhesive capsulitis of the shoulder induced by protease inhibitor therapy. Three new cases. Revue du rhumatisme (English ed.), 1998, Volume: 65, Issue:12 Topics: Adult; Bursitis; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Shoulder Joint; Stavudine	1998
[Clinical case of the month. Apropos of pancytopenia in a seropositive patient]. Revue medicale de Liege, 1998, Volume: 53, Issue:12 Topics: Adult; Anemia, Aplastic; Anti-HIV Agents; Bone Marrow; HIV Infections; HIV Seropositivity; HIV-1; Humans; Indinavir; Lamivudine; Male; Pancytopenia; Stavudine; Zidovudine	1998
PHS recommends preventive drugs for HIV exposures. OR manager, 1996, Volume: 12, Issue:8 Topics: Antiviral Agents; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Occupational Exposure; Pyridines; United States; United States Public Health Service; Virus Replication; Zalcitabine; Zidovudine	1996
Highly active antiretroviral therapy used to treat concurrent hepatitis B and human immunodeficiency virus infections. Journal of gastroenterology, 1999, Volume: 34, Issue:2 Topics: Adult; Anti-HIV Agents; Biopsy, Needle; Drug Therapy, Combination; Gene Products, pol; Hepatitis B Antibodies; Hepatitis B, Chronic; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Liver; Male; Zidovudine	1999
Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trial. AIDS research and human retroviruses, 1999, Apr-10, Volume: 15, Issue:6 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Cost-Benefit Analysis; Costs and Cost Analysis; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Models, Biological; Models, Economic; Outcome and Process Assessment, Health Care; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Zidovudine	1999
[Infectious diseases in 1998]. La Revue de medecine interne, 1999, Volume: 20, Issue:4 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-HIV Agents; Antiviral Agents; Bacterial Vaccines; Blood Donors; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Interferons; Lamivudine; Middle Aged; Multicenter Studies as Topic; Pneumonia, Pneumococcal; Randomized Controlled Trials as Topic; Ribavirin; Streptococcus pneumoniae; Transfusion Reaction; Zidovudine	1999
Paronychia associated with antiretroviral therapy. The British journal of dermatology, 1999, Volume: 140, Issue:6 Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Clobetasol; Drug Therapy, Combination; Female; Glucocorticoids; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Mupirocin; Paronychia	1999
Needle-stick injuries and HIV infection: a surgeon's personal experience and review of postexposure prophylaxis. St. Paul's Ocular AIDS Group. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1999, Volume: 34, Issue:4 Topics: Anti-HIV Agents; Dacryocystorhinostomy; Drug Therapy, Combination; HIV Infections; HIV Seropositivity; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Male; Middle Aged; Needlestick Injuries; Occupational Exposure; Ophthalmology; Primary Prevention; Risk Factors; Zidovudine	1999
Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. Journal of virology, 1999, Volume: 73, Issue:8 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cytotoxicity, Immunologic; Drug Therapy, Combination; Epitopes, T-Lymphocyte; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Longitudinal Studies; Reverse Transcriptase Inhibitors; Stavudine; T-Lymphocytes, Cytotoxic; Viral Load; Viremia; Zidovudine	1999
Antiviral effect of AZT versus stavudine in combination with lamivudine and indinavir in the context of a populational study. Journal of acquired immune deficiency syndromes (1999), 1999, Aug-01, Volume: 21, Issue:4 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Stavudine; Viremia; Zidovudine	1999
The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination. American journal of obstetrics and gynecology, 1999, Volume: 181, Issue:3 Topics: Adult; Antiviral Agents; Female; HIV Infections; HIV Seropositivity; Humans; Indinavir; Insemination, Artificial, Heterologous; Lamivudine; Male; Pregnancy; Tissue Donors; Zidovudine	1999
Diabetic ketoacidosis in an HIV patient: a new mechanism of HIV protease inhibitor-induced glucose intolerance. AIDS (London, England), 1999, Oct-01, Volume: 13, Issue:14 Topics: Diabetic Ketoacidosis; Drug Therapy, Combination; Glucose Intolerance; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine	1999
Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort study. Scandinavian journal of infectious diseases, 1999, Volume: 31, Issue:5 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Controlled Clinical Trials as Topic; Denmark; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Multicenter Studies as Topic; Retrospective Studies; Ritonavir; RNA, Viral; Saquinavir; Viral Load; Zidovudine	1999
Highly active antiretroviral therapy: progress and pitfalls. The Journal of pediatrics, 1999, Volume: 135, Issue:6 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; HIV Infections; Humans; Indinavir; Lamivudine; Stavudine; Virus Replication	1999
Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection. The Journal of pediatrics, 1999, Volume: 135, Issue:6 Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Cell Division; Child; Drug Therapy, Combination; HIV Infections; Humans; Hypersensitivity, Delayed; Indinavir; Infectious Disease Transmission, Vertical; Lamivudine; Skin Tests; Stavudine; T-Lymphocytes; Treatment Outcome	1999
Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. AIDS (London, England), 1999, Dec-03, Volume: 13, Issue:17 Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Adult; Anti-HIV Agents; Antigens, CD; Antigens, Differentiation; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; HIV Infections; HIV-1; HLA-DR Antigens; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Male; Membrane Glycoproteins; NAD+ Nucleosidase; Palatine Tonsil; Proviruses; T-Lymphocyte Subsets; Time Factors; Viremia; Virus Replication; Zidovudine	1999
Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort. AIDS research and human retroviruses, 1999, Dec-10, Volume: 15, Issue:18 Topics: Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Disease Progression; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Incidence; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Ritonavir; RNA, Viral; Salvage Therapy; Saquinavir; Stavudine; Switzerland; Treatment Failure; Viral Load; Zalcitabine; Zidovudine	1999
Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection. The Journal of infectious diseases, 2000, Volume: 181, Issue:1 Topics: Acute Disease; Adult; Anti-HIV Agents; Candida; CD4 Lymphocyte Count; Chronic Disease; Cytokines; Cytotoxicity, Immunologic; Drug Therapy, Combination; Female; HIV Antigens; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Male; Middle Aged; Prospective Studies; T-Lymphocytes; Tetanus Toxoid; Viral Load; Zidovudine	2000
Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: adherence, side effects and efficacy. The Journal of infection, 1999, Volume: 39, Issue:2 Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Patient Compliance; Reverse Transcriptase Inhibitors; Stavudine; Substance Abuse, Intravenous	1999
Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity. Journal of clinical microbiology, 2000, Volume: 38, Issue:1 Topics: Adult; Anti-HIV Agents; Female; Guinea; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Spain; Stavudine; Viral Load; Viremia	2000
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens. JAMA, 2000, Jan-12, Volume: 283, Issue:2 Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Phenotype; RNA, Viral; Treatment Failure; Viral Load; Zidovudine	2000
[Fatal lactic acidosis in a patient with acquired immunodeficiency syndrome treated with stavudine, lamivudine and indinavir]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1999, Volume: 73, Issue:12 Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; Fatal Outcome; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine	1999
Effortless unintentional smoking cessation after lamivudine-zidovudine-indinavir post-exposure anti-HIV chemoprophylaxis. Addiction (Abingdon, England), 1999, Volume: 94, Issue:1 Topics: Adult; Anti-HIV Agents; HIV Infections; Humans; Indinavir; Lamivudine; Male; Smoking; Smoking Cessation; Zidovudine	1999
Induction and maintenance treatment regimens for HIV-1 infection in vitro. Antiviral therapy, 1999, Volume: 4, Issue:1 Topics: Anti-HIV Agents; Cell Line; DNA, Viral; HIV-1; Humans; Indinavir; Lamivudine; Zidovudine	1999
Improvement of anemia induced by parvovirus B19 in a patient with AIDS after combined antiretroviral therapy. Mayo Clinic proceedings, 2000, Volume: 75, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Anemia, Aplastic; Anti-HIV Agents; Female; Humans; Indinavir; Lamivudine; Parvoviridae Infections; Parvovirus B19, Human; Stavudine; Treatment Outcome	2000
[Thrombocytopenic thrombotic purpura, HIV, and antiviral therapy]. Revista clinica espanola, 1999, Volume: 199, Issue:12 Topics: Adult; Anti-HIV Agents; HIV Infections; Humans; Indinavir; Lamivudine; Purpura, Thrombotic Thrombocytopenic; Stavudine	1999
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality. Blood, 2000, Mar-01, Volume: 95, Issue:5 Topics: Acute Disease; Anti-HIV Agents; Clone Cells; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Saquinavir; T-Lymphocytes, Cytotoxic; Viremia; Zidovudine	2000
Tolerability and side-effects of post-exposure prophylaxis for HIV infection. Lancet (London, England), 2000, Feb-26, Volume: 355, Issue:9205 Topics: Anti-HIV Agents; Drug Combinations; Drug Tolerance; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; London; Needlestick Injuries; Patient Compliance; Personnel, Hospital; Retrospective Studies; Zidovudine	2000
Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection. AIDS research and human retroviruses, 2000, Feb-10, Volume: 16, Issue:3 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Male; Palatine Tonsil; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Time Factors; Viremia; Zidovudine	2000
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS (London, England), 2000, Feb-18, Volume: 14, Issue:3 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child; Cohort Studies; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Organ Size; Reverse Transcriptase Inhibitors; Stavudine; Thymus Gland; Viral Load; Zidovudine	2000
The triple combination indinavir-zidovudine-lamivudine is highly synergistic. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:4 Topics: Anti-HIV Agents; Cells, Cultured; Coloring Agents; Drug Synergism; HIV-1; Humans; Indinavir; Lamivudine; Tetrazolium Salts; Zidovudine	2000
[A two-year follow-up of zidovudine plus lamivudine combined with indinavir in antivival naive HIV-infected patients]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2000, Volume: 74, Issue:2 Topics: Anti-HIV Agents; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Zidovudine	2000
Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency. Journal of virology, 2000, Volume: 74, Issue:9 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cell Lineage; Drug Therapy, Combination; Gene Products, gag; Gene Products, pol; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Interferon-gamma; Lamivudine; Longitudinal Studies; Lymphocyte Activation; Peptides; Phenotype; Phosphoproteins; Reverse Transcriptase Inhibitors; T-Lymphocytes, Cytotoxic; Viral Load; Viral Matrix Proteins; Zidovudine	2000
[Cutaneous porphyria cure in a patient infected with human immunodeficiency virus treated with triple therapy]. La Revue de medecine interne, 2000, Volume: 21, Issue:3 Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Hepatitis C; HIV Seropositivity; Humans; Indinavir; Lamivudine; Male; Opioid-Related Disorders; Porphyria Cutanea Tarda; Remission, Spontaneous; Stavudine	2000
The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome. International journal of STD & AIDS, 2000, Volume: 11, Issue:4 Topics: Adolescent; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Infant; Lamivudine; Male; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Treatment Outcome; Zidovudine	2000
Efavirenz in HIV infection. The New England journal of medicine, 2000, Apr-27, Volume: 342, Issue:17 Topics: Alkynes; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Oxazines; Research Design; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine	2000
Highly active antiretroviral therapy inhibits cytokine production in HIV-uninfected subjects. AIDS (London, England), 2000, Apr-14, Volume: 14, Issue:6 Topics: Adult; Anti-HIV Agents; Child; Cytokines; Drug Therapy, Combination; HIV Infections; HIV Seronegativity; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Zidovudine	2000
[A case of HIV encephalopathy with dementia which showed significant improvement after the combination antiretroviral therapy]. Rinsho shinkeigaku = Clinical neurology, 2000, Volume: 40, Issue:2 Topics: AIDS Dementia Complex; Anti-HIV Agents; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Treatment Outcome; Zidovudine	2000
Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum. The Journal of infection, 2000, Volume: 40, Issue:2 Topics: Adult; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Indinavir; Lamivudine; Leishmania infantum; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Stavudine	2000
Cutaneous side effects induced by indinavir. European journal of dermatology : EJD, 2000, Volume: 10, Issue:4 Topics: Adult; Alopecia; Didanosine; Drug Eruptions; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lipodystrophy; Male; Middle Aged; Pruritus; Pyoderma Gangrenosum; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Scalp Dermatoses; Skin; Stavudine; Zalcitabine; Zidovudine	2000
Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis. Annals of internal medicine, 2000, Jul-04, Volume: 133, Issue:1 Topics: Adolescent; Anti-HIV Agents; Drug Administration Schedule; Drug Therapy, Combination; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Transfusion Reaction; Zidovudine	2000
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. AIDS (London, England), 2000, Jun-16, Volume: 14, Issue:9 Topics: Adult; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Disease Reservoirs; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Semen; Stavudine; Viral Load; Zidovudine	2000
[Evaluation of the effect of early and massive tritherapy on the expression of cellular factors potentially implicated in antiretroviral therapy resistance]. Pathologie-biologie, 2000, Volume: 48, Issue:5 Topics: Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Microbial; Gene Expression; Indinavir; Lamivudine; Macaca fascicularis; Male; Nucleoside-Phosphate Kinase; RNA, Messenger; Simian Acquired Immunodeficiency Syndrome; Thymidine Kinase; Zidovudine	2000
Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC]. Antiviral chemistry & chemotherapy, 2000, Volume: 11, Issue:4 Topics: Anti-HIV Agents; Cells, Cultured; Deoxycytidine; Didanosine; Drug Combinations; Drug Resistance, Microbial; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Molecular Structure; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Stavudine; T-Lymphocytes; Thionucleosides; Zidovudine	2000
Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication. AIDS (London, England), 2000, Jul-28, Volume: 14, Issue:11 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Models, Biological; Predictive Value of Tests; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Virus Replication; Zidovudine	2000
Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy. Immunobiology, 2000, Volume: 202, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cytomegalovirus Retinitis; Female; Hepatitis C; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Reverse Transcriptase Inhibitors; Zidovudine	2000
[Cost effectiveness analysis of highly active antiretroviral therapy in HIV asymptomatic patients]. Medicina clinica, 2000, Volume: 114 Suppl 3 Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Didanosine; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nevirapine; Sickness Impact Profile; Spain; Stavudine; Viral Load; Zidovudine	2000
[Antiretroviral therapy in HIV infection. Effects of the introduction of new drugs on health care expenditures, 1994-1999]. Recenti progressi in medicina, 2000, Volume: 91, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cohort Studies; Drug Costs; Drug Prescriptions; Health Expenditures; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Italy; Lamivudine; Retrospective Studies; Reverse Transcriptase Inhibitors	2000
Sudden unexpected death as a consequence of indinavir-induced nephropathy. A case report. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2000, Volume: 108, Issue:9 Topics: Acute Kidney Injury; AIDS Dementia Complex; Antiretroviral Therapy, Highly Active; Crystallization; Death, Sudden, Cardiac; Diagnosis, Differential; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Solubility; Stavudine; Syncope; Ventricular Fibrillation; Water-Electrolyte Imbalance	2000
Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated during early versus advanced states of HIV disease. Journal of acquired immune deficiency syndromes (1999), 2000, Dec-01, Volume: 25, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal; Antiretroviral Therapy, Highly Active; Female; Flow Cytometry; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Lymphocyte Count; Male; Middle Aged; Pilot Projects; Prospective Studies; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; RNA, Viral; Scintillation Counting; Statistics, Nonparametric; Stavudine; T-Lymphocyte Subsets; Tritium; Viral Load	2000
Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS? AIDS patient care and STDs, 2000, Volume: 14, Issue:12 Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Case-Control Studies; CD4 Lymphocyte Count; Female; Gingivitis; Herpes Labialis; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Leukoplakia, Hairy; Male; Middle Aged; Mouth Diseases; Periodontitis; Prevalence; Viral Load; Xerostomia; Zidovudine	2000
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. Proceedings of the National Academy of Sciences of the United States of America, 2001, Jan-16, Volume: 98, Issue:2 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Depression, Chemical; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hydroxyurea; Immunity, Cellular; Indinavir; Lamivudine; Lymphocyte Count; Male; Middle Aged; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Refusal; Viral Load; Viremia; Zidovudine	2001
Indinavir, zidovudine, lamivudine: 3-year follow-up. Annals of internal medicine, 2001, Jan-16, Volume: 134, Issue:2 Topics: Anti-HIV Agents; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Kidney Calculi; Lamivudine; Risk Factors; Zidovudine	2001
Association between high serum prolactin levels and concomitant infections in HIV-infected patients. Human immunology, 2001, Volume: 62, Issue:2 Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; CD4-CD8 Ratio; Female; HIV Infections; Humans; Immunoglobulins; Indinavir; Lamivudine; Male; Prolactin; Sex Factors; T-Lymphocyte Subsets; Trimethoprim, Sulfamethoxazole Drug Combination; Viral Load; Zidovudine	2001
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2. AIDS (London, England), 2001, Jan-05, Volume: 15, Issue:1 Topics: Anti-HIV Agents; Antigens, CD; Antiretroviral Therapy, Highly Active; B7-2 Antigen; CD4 Lymphocyte Count; CD58 Antigens; Fas Ligand Protein; HIV Infections; HIV Protease Inhibitors; HIV-1; HLA-DR Antigens; Humans; Indinavir; Interleukin-2; L-Selectin; Lamivudine; Leukocyte Common Antigens; Membrane Glycoproteins; Membrane Proteins; Reverse Transcriptase Inhibitors; Stavudine; Viremia; Virion	2001
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS (London, England), 2001, Jan-05, Volume: 15, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Bone Diseases, Metabolic; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Osteoporosis; Reverse Transcriptase Inhibitors; Rib Fractures; Spinal Fractures; Stavudine	2001
[Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy]. Rinsho shinkeigaku = Clinical neurology, 2000, Volume: 40, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Aged; Antiretroviral Therapy, Highly Active; Humans; Indinavir; JC Virus; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Male; Treatment Outcome; Zidovudine	2000
In vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposure. Journal of clinical microbiology, 2001, Volume: 39, Issue:3 Topics: Drug Resistance, Microbial; Drug Resistance, Multiple; Evolution, Molecular; Gene Products, gag; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Microbial Sensitivity Tests; Molecular Sequence Data; Reverse Transcriptase Inhibitors; Zidovudine	2001
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2000, Volume: 4, Issue:4 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Viral; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Polymerase Chain Reaction; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viremia; Zidovudine	2000
Resolution of microsporidial keratoconjunctivitis in an AIDS patient treated with highly active antiretroviral therapy. American journal of ophthalmology, 2001, Volume: 131, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Eye Infections, Parasitic; Female; Humans; Indinavir; Keratoconjunctivitis; Lamivudine; Microsporidia; Microsporidiosis; Stavudine; Visual Acuity	2001
[Bilateral hip necrosis, corticoids, and human immunodeficiency virus protease inhibitors]. Enfermedades infecciosas y microbiologia clinica, 2001, Volume: 19, Issue:1 Topics: Aged; Antiretroviral Therapy, Highly Active; Dexamethasone; Didanosine; Femur Head Necrosis; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Prednisone; Zidovudine	2001
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. The Journal of infectious diseases, 2001, May-01, Volume: 183, Issue:9 Topics: Cohort Studies; DNA, Viral; Female; Genitalia; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Lymph Nodes; Male; Molecular Sequence Data; Randomized Controlled Trials as Topic; RNA, Viral; Time Factors; Viral Load; Viremia; Virus Replication; Zidovudine	2001
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:2 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Statistics, Nonparametric; Viral Load; Viremia; Virus Shedding; Zidovudine	2001
Smaller amounts of antiretroviral drugs are needed when combined with an active ribozyme against HIV-1. Molecular therapy : the journal of the American Society of Gene Therapy, 2001, Volume: 3, Issue:4 Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cell Line; Cyclopropanes; Didanosine; Dose-Response Relationship, Drug; Enzyme Inhibitors; HIV Core Protein p24; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Protease Inhibitors; Reverse Transcriptase Inhibitors; RNA, Catalytic; T-Lymphocytes; Time Factors	2001
Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Jun-01, Volume: 32, Issue:11 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Interactions; Female; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Indinavir; Lamivudine; Nelfinavir; Occupational Exposure; Reverse Transcriptase Inhibitors; Thyroxine; Zidovudine	2001
Undetectable HIV levels after triple therapy with indinavir. AIDS patient care and STDs, 1997, Volume: 11, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; RNA, Viral; Viral Load; Zidovudine	1997
ACTG 320 trial halted as three-drug arm proves superior. AIDS patient care and STDs, 1997, Volume: 11, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; United States; Zidovudine	1997
HAART therapy: dividing the epidemic? AIDS patient care and STDs, 1997, Volume: 11, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Zidovudine	1997
Head-to-head study of protease inhibitors. AIDS patient care and STDs, 1998, Volume: 12, Issue:1 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Saquinavir; Zidovudine	1998
Data in from first head-to-head protease inhibitor. AIDS patient care and STDs, 1998, Volume: 12, Issue:4 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Saquinavir; Viral Load; Zidovudine	1998
Double protease inhibitor regimens with amprenavir show promise. AIDS patient care and STDs, 1998, Volume: 12, Issue:4 Topics: Anti-HIV Agents; Carbamates; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Saquinavir; Sulfonamides; Viral Load; Zidovudine	1998
AIDS task force grapples with faster access to protease drugs. Journal of the International Association of Physicians in AIDS Care, 1995, Volume: 1, Issue:2 Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Drug Approval; Drug Design; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Pyridines; Treatment Outcome; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine	1995
3TC and protease inhibitors: citizen's petition asks faster approval. AIDS treatment news, 1995, Apr-07, Issue:no 220 Topics: Drug Approval; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Pyridines; United States; United States Food and Drug Administration; Zalcitabine	1995
Treatment briefs. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:4 Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Industry; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Nerve Growth Factors; Nervous System Diseases; Pyridines; Recombinant Proteins; Stavudine; Zalcitabine; Zidovudine	1995
A Lisbon traviata. Are clinicians ready to sing addio to monotherapy and libiamo to combinations? Journal of the International Association of Physicians in AIDS Care, 1995, Volume: 1, Issue:8 Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; HIV; HIV Infections; Humans; Hydroxyurea; Indinavir; Interleukin-2; Lamivudine; Mutation; Pyridines; RNA, Viral; Zalcitabine; Zidovudine	1995
Protease inhibitors and prevention of cross resistance. AIDS treatment news, 1995, Oct-06, Issue:no 232 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Carbamates; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Lamivudine; Nelfinavir; Pyridines; Quinolines; Saquinavir; Sulfonamides; Zalcitabine; Zidovudine	1995
Conference looks at HIV drug resistance. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:9 Topics: Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Microbial; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine; Viremia; Zalcitabine; Zidovudine	1995
Merck protease inhibitor: more news from Retroviruses Conference. AIDS treatment news, 1996, Feb-16, Issue:no 241 Topics: CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Pyridines; Zalcitabine; Zidovudine	1996
Protease inhibitors shine in triple combinations. AIDS alert, 1996, Volume: 11, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Pyridines; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine	1996
CDC takes aggressive stance on postexposure prophylaxis. Centers for Disease Control and Prevention. AIDS alert, 1996, Volume: 11, Issue:7 Topics: Antiviral Agents; Blood-Borne Pathogens; Centers for Disease Control and Prevention, U.S.; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Exposure; Pyridines; Risk Factors; United States; Zalcitabine; Zidovudine	1996
Nipping HIV in the bud. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:8 Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication; Zalcitabine; Zidovudine	1996
Eradication of HIV: the cutting edge of clinical trial design. Critical Path AIDS project, 1996,Fall, Issue:No 31 Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Pyridines; Zalcitabine; Zidovudine	1996
Study shows three drugs better than two. AIDS alert, 1997, Volume: 12, Issue:4 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Stavudine; United States; Zidovudine	1997
Study confirms that protease inhibitor cocktail can delay HIV disease progression and death. NIAID AIDS agenda, 1997 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; United States; Zidovudine	1997
ACTG 320: last of the body count trials? PI perspective, 1997, Issue:No 21 Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethics, Medical; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; Zidovudine	1997
New recommendations on health care worker exposure to HIV. STEP perspective, 1996,Fall, Volume: 8, Issue:3 Topics: Anti-HIV Agents; Disease Transmission, Infectious; Drug Therapy, Combination; Guidelines as Topic; Health Personnel; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Occupational Exposure; Risk Factors; Viral Load; Zidovudine	1996
Spring cleaning in trial land. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1997, Volume: 11, Issue:3 Topics: Anti-HIV Agents; Brazil; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Saquinavir; Stavudine; United States; Viral Load; Zidovudine	1997
Treating a survivor. AIDS clinical care, 1997, Volume: 9, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Counseling; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Mycobacterium avium-intracellulare Infection; Pneumonia, Pneumocystis; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Zidovudine	1997
3-drug therapy reduces deaths and new AIDS-related illnesses by 50%. BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1997 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine	1997
ACTG 343: three drugs better than two for maintaining HIV suppression. NIAID AIDS agenda, 1998 Topics: AIDS Vaccines; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Saquinavir; Stavudine; Viral Load; Zidovudine	1998
Giving improper dose of HIV drug is not proof of indifference. AIDS policy & law, 1998, Jun-26, Volume: 13, Issue:12 Topics: Anti-HIV Agents; Disabled Persons; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Prisoners; Reverse Transcriptase Inhibitors; Texas; Zidovudine	1998
Lower dose maintenance therapy? Project Inform perspective, 1998, Issue:24 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; RNA, Viral; Viral Load; Zidovudine	1998
First once-daily drug simplifies dosing, offers new options in HIV-1 treatment. AIDS alert, 1998, Volume: 13, Issue:11 Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Patient Compliance; Reverse Transcriptase Inhibitors; Zidovudine	1998
Triple-drug therapy may mean lifelong commitment. AIDS alert, 1999, Volume: 14, Issue:1 Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; France; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Patient Compliance; United States; Zidovudine	1999
New study shows efavirenz effective with d4T and 3TC. AIDS alert, 1999, Volume: 14, Issue:5 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cerebrospinal Fluid; Clinical Trials as Topic; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Oxazines; Reverse Transcriptase Inhibitors; Stavudine; Vagina; Viral Load; Zidovudine	1999
Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization. AIDS research and human retroviruses, 2001, May-01, Volume: 17, Issue:7 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Progression; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Lymphoid Tissue; Phenotype; Proviruses; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Viral Load; Viremia; Virus Replication; Zidovudine	2001
CT appearances of HIV-related lipodystrophy syndrome. The British journal of radiology, 2001, Volume: 74, Issue:880 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Mass Index; HIV Infections; Humans; Indinavir; Lamivudine; Lipodystrophy; Male; Tomography, X-Ray Computed; Treatment Outcome; Zidovudine	2001
Prevalence and predictive value of intermittent viremia with combination hiv therapy. JAMA, 2001, Jul-11, Volume: 286, Issue:2 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Predictive Value of Tests; Prevalence; Proportional Hazards Models; Retrospective Studies; RNA, Viral; Viral Load; Viremia; Virus Replication; Zidovudine	2001
A pilot trial of indinavir, ritonavir, didanosine, and lamivudine in a once-daily four-drug regimen for HIV infection. Journal of acquired immune deficiency syndromes (1999), 2001, Jul-01, Volume: 27, Issue:3 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cholesterol; Didanosine; Drug Evaluation; Drug Therapy, Combination; Genotype; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Pilot Projects; Ritonavir; Safety; Treatment Outcome; Triglycerides; Viral Load	2001
Antiretroviral rounds. When success is a pain. AIDS clinical care, 2001, Volume: 13, Issue:8 Topics: Abdominal Pain; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Nelfinavir; Oxazines; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine	2001
Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice. Laboratory investigation; a journal of technical methods and pathology, 2001, Volume: 81, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atrial Natriuretic Factor; Calcium-Transporting ATPases; Cardiomyopathies; Drug Therapy, Combination; Echocardiography; Gene Expression; HIV Protease Inhibitors; Indinavir; Lactic Acid; Lamivudine; Mice; Mice, Transgenic; Microscopy, Electron; Myocardium; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Zidovudine	2001
Summaries for patients. Predictors of outcomes in patients with HIV infection treated with indinavir, zidovudine, and lamivudine. Annals of internal medicine, 2001, Dec-04, Volume: 135, Issue:11 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Protocols; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; RNA, Viral; Viral Load; Zidovudine	2001
Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. AIDS (London, England), 2002, Jan-25, Volume: 16, Issue:2 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD28 Antigens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; HIV Antigens; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunophenotyping; Indinavir; Interferon-gamma; Lamivudine; Membrane Glycoproteins; Palatine Tonsil; Perforin; Pore Forming Cytotoxic Proteins; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome	2002
Clinical trials group: two studies are now open to patients who qualify. HIV clinician, 2000,Winter, Volume: 12, Issue:1 Topics: Alkynes; Benzoxazines; CD4 Lymphocyte Count; Clinical Trials as Topic; Cyclopropanes; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Oxazines; Patient Selection; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Viral Load; Zidovudine	2000
[Post-exposure prophylaxis in Zambia; the experiences of a tropical disease specialist following a cut accidentally incurred while operating on an HIV positive patient]. Nederlands tijdschrift voor geneeskunde, 2002, Mar-30, Volume: 146, Issue:13 Topics: Adult; Anti-HIV Agents; Health Personnel; HIV Infections; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Male; Reverse Transcriptase Inhibitors; Zambia; Zidovudine	2002
The human 26S proteasome is a target of antiretroviral agents. AIDS (London, England), 2002, Mar-29, Volume: 16, Issue:5 Topics: Anti-HIV Agents; DNA-Binding Proteins; Drug Delivery Systems; HIV Protease Inhibitors; Humans; I-kappa B Proteins; Indinavir; Jurkat Cells; Lamivudine; NF-kappa B; NF-KappaB Inhibitor alpha; Peptide Hydrolases; Proteasome Endopeptidase Complex; Reverse Transcriptase Inhibitors; Ubiquitin; Zidovudine	2002
Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy. AIDS (London, England), 2002, Mar-29, Volume: 16, Issue:5 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Follow-Up Studies; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load; Virus Replication; Zidovudine	2002
A case of flare syndrome. Le infezioni in medicina, 2001, Volume: 9, Issue:3 Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Ganciclovir; HIV Infections; Humans; Indinavir; Lamivudine; Male; Organophosphonates; Organophosphorus Compounds; Zidovudine	2001
Immunophenotypic analyses of CD34(+) cell subsets in bone marrow from HIV-infected patients during highly- active antiretroviral therapy. European journal of clinical investigation, 2002, Volume: 32, Issue:7 Topics: Adult; Antigens, CD34; Antiretroviral Therapy, Highly Active; beta 2-Microglobulin; Bone Marrow Cells; Case-Control Studies; Female; Flow Cytometry; HIV Infections; HIV Protease Inhibitors; Humans; Immunoglobulin G; Immunophenotyping; Indinavir; Lamivudine; Leukocyte Count; Male; Middle Aged; Stavudine; T-Lymphocyte Subsets; Zidovudine	2002
AIDS-related primary central nervous system lymphoma: prolonged remission associated with highly active antiretroviral therapy. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2002, Volume: 85, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Brain Neoplasms; HIV Seropositivity; Humans; Indinavir; Lamivudine; Lymphoma, AIDS-Related; Male; Radiography; Stavudine; Ventriculoperitoneal Shunt	2002
Immune reconstitution during intensive chemotherapy in patients with human immunodeficiency virus related non-Hodgkin lymphoma. The hematology journal : the official journal of the European Haematology Association, 2002, Volume: 3, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; HIV Infections; HIV Protease Inhibitors; Humans; Immunocompromised Host; Immunosuppression Therapy; Indinavir; Lamivudine; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Prednisone; Reverse Transcriptase Inhibitors; Stavudine; T-Lymphocyte Subsets; Vincristine	2002
Type B lactic acidosis: a rare complication of antiretroviral therapy after cardiac surgery. The Annals of thoracic surgery, 2002, Volume: 74, Issue:4 Topics: Acidosis, Lactic; Anti-HIV Agents; Aortic Valve; Female; Heart Valve Prosthesis; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Kidney Failure, Chronic; Lamivudine; Middle Aged; Postoperative Complications; Renal Dialysis; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine	2002
Indirect hyperbilirubinemia with indinavir. The Journal of the Association of Physicians of India, 2002, Volume: 50 Topics: Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; India; Indinavir; Lamivudine; Liver Function Tests; Needlestick Injuries; Prognosis; Risk Assessment; Severity of Illness Index; Zidovudine	2002
[Measuring the HIV viral load with LCx (Abbott): importance for the therapeutic follow-up of 3 patients infected by type O HIV]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2003, Volume: 10, Issue:2 Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Oxazines; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Viral Load; Viremia; Zidovudine	2003
Latrogenic nephrogenic diabetes insipidus. AIDS (London, England), 2003, Jun-13, Volume: 17, Issue:9 Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Diabetes Insipidus, Nephrogenic; HIV Infections; Humans; Indinavir; Lamivudine; Male; Ritonavir; Stavudine	2003
[Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy]. Anales de medicina interna (Madrid, Spain : 1984), 2003, Volume: 20, Issue:5 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Didanosine; Drug Evaluation; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Treatment Outcome; Viral Load; Zidovudine	2003
Sequential cutaneous drug reactions to protease inhibitors in the context of occupational post-exposure prophylaxis. AIDS (London, England), 2003, Jul-25, Volume: 17, Issue:11 Topics: Adult; Drug Hypersensitivity; Female; Guideline Adherence; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Needlestick Injuries; Occupational Diseases; Occupational Exposure; Zidovudine	2003
Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals. Antiviral therapy, 2003, Volume: 8, Issue:6 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Prospective Studies; Ritonavir; Stavudine; Zidovudine	2003
Buffalo hump: what the experts suggest. AIDS clinical care, 2004, Volume: 16, Issue:3 Topics: Adult; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lipodystrophy; Male; Reverse Transcriptase Inhibitors; Zidovudine	2004
Lamivudine 300 mg in HIV infection: dose change. Once-a-day dosing. Prescrire international, 2004, Volume: 13, Issue:70 Topics: Adult; Child; Drug Therapy, Combination; France; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Protease Inhibitors; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine	2004
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? Neurology, 2004, Dec-28, Volume: 63, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Brain; CD4 Lymphocyte Count; Cidofovir; Cytosine; Dideoxynucleosides; Encephalitis; False Negative Reactions; Fatal Outcome; Humans; Immunocompromised Host; Indinavir; JC Virus; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Organophosphonates; Substance Abuse, Intravenous; Time Factors; Virus Activation; Zidovudine	2004
Postexposure prophylaxis after sexual assaults: a prospective cohort study. Sexually transmitted diseases, 2005, Volume: 32, Issue:4 Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Brazil; Child; Child, Preschool; Cohort Studies; Drug Administration Schedule; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nelfinavir; Patient Compliance; Prospective Studies; Rape; Sexually Transmitted Diseases; Zidovudine	2005
Highly active antiretroviral therapy and human immunodeficiency virus encephalitis. Annals of neurology, 2005, Volume: 57, Issue:6 Topics: AIDS Dementia Complex; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brain; Disease Models, Animal; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Mice; Mice, SCID; Monocytes; Viral Load; Zidovudine	2005
T-cell line for HIV drug screening using EGFP as a quantitative marker of HIV-1 replication. BioTechniques, 2006, Volume: 40, Issue:1 Topics: Amides; Anti-HIV Agents; Biomarkers; CCR5 Receptor Antagonists; Cell Culture Techniques; Cell Line; Genes, Reporter; Green Fluorescent Proteins; HIV Antibodies; HIV Fusion Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Microbial Sensitivity Tests; Microscopy, Fluorescence; Quaternary Ammonium Compounds; Reverse Transcriptase Inhibitors; RNA, Viral; T-Lymphocytes; Virus Replication	2006
Real-time nucleic acid sequence-based amplification assay to quantify changes in mitochondrial DNA concentrations in cell cultures and blood cells from HIV-infected patients receiving antiviral therapy. Clinical chemistry, 2006, Volume: 52, Issue:6 Topics: Anti-HIV Agents; Base Sequence; Blood Platelets; Cell Nucleus; Cells, Cultured; Didanosine; DNA, Mitochondrial; Drug Therapy, Combination; Feasibility Studies; Fibroblasts; HIV Infections; Humans; Indinavir; Lactic Acid; Lamivudine; Leukocytes, Mononuclear; Nucleic Acid Amplification Techniques; Pyruvic Acid; Stavudine; Zalcitabine	2006
[Pneumocystis jirovecii pneumonia: an old disease with a new name]. Medicina (Kaunas, Lithuania), 2006, Volume: 42, Issue:8 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents, Urinary; Antifungal Agents; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; Folic Acid Antagonists; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Radiography, Thoracic; Trimethoprim; Zidovudine	2006
Less sensitive HIV-1 enzyme immunoassay as an adjuvant method for monitoring patients receiving antiretroviral therapy. AIDS patient care and STDs, 2007, Volume: 21, Issue:2 Topics: Anti-HIV Agents; Drug Monitoring; HIV Infections; HIV-1; Immunoenzyme Techniques; Indinavir; Lamivudine; Sensitivity and Specificity; Time Factors; Virus Replication; Zidovudine	2007
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. Journal of acquired immune deficiency syndromes (1999), 2007, May-01, Volume: 45, Issue:1 Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Black People; Cholesterol; Cross-Sectional Studies; Cyclopropanes; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; Fasting; Female; Hispanic or Latino; HIV Infections; HIV Protease Inhibitors; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Indinavir; Lamivudine; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Multivariate Analysis; Nelfinavir; Nevirapine; Organophosphonates; Ritonavir; Stavudine; Tenofovir; Triglycerides; United States; White People	2007
[Rapid development of anemia in a HIV-positive patient with alpha-thalassemia after zidovudine therapy]. Mikrobiyoloji bulteni, 2007, Volume: 41, Issue:3 Topics: Adult; alpha-Thalassemia; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Diagnosis, Differential; Folic Acid; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Zidovudine	2007
Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement. Journal of neurovirology, 2008, Volume: 14, Issue:1 Topics: Adenine; Adult; AIDS Dementia Complex; Alkynes; Anti-HIV Agents; Anticonvulsants; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cerebrospinal Fluid; Cyclopropanes; Didanosine; HIV-1; Humans; Indinavir; Lamivudine; Male; Nelfinavir; Nevirapine; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; Seizures; Stavudine; Tenofovir; Viral Load; Virus Replication; Zidovudine	2008
Murine cardiac mtDNA: effects of transgenic manipulation of nucleoside phosphorylation. Laboratory investigation; a journal of technical methods and pathology, 2009, Volume: 89, Issue:2 Topics: Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cardiomyopathy, Dilated; Cell Line; DNA, Mitochondrial; Echocardiography; Female; Heart Ventricles; Hypertrophy, Left Ventricular; Indinavir; Lamivudine; Male; Mice; Mice, Transgenic; Mitochondria, Heart; Myocytes, Cardiac; Phosphorylation; Reverse Transcriptase Inhibitors; Thymidine Kinase; Zidovudine	2009
Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir. AIDS (London, England), 2009, Feb-20, Volume: 23, Issue:4 Topics: Administration, Oral; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Indinavir; Injections, Subcutaneous; Lamivudine; Macaca fascicularis; Sexually Transmitted Diseases, Viral; Simian Acquired Immunodeficiency Syndrome; Vagina; Viral Load; Viremia; Zidovudine	2009
[Atazanavir-induced nephrolithiasis]. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:2 Topics: Adenine; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D, Chronic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lopinavir; Male; Nephrolithiasis; Oligopeptides; Organophosphonates; Pyridines; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Tenofovir	2009
Specification of covariance structure in longitudinal data analysis for randomized clinical trials. Statistics in medicine, 2010, Feb-20, Volume: 29, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Bias; CD4 Lymphocyte Count; Computer Simulation; Humans; Indinavir; Lamivudine; Longitudinal Studies; Models, Statistical; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Zidovudine	2010
Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion. Retrovirology, 2010, Sep-26, Volume: 7 Topics: Administration, Cutaneous; Administration, Oral; Animals; Antiretroviral Therapy, Highly Active; Drug Administration Schedule; HIV Protease Inhibitors; Indinavir; Lamivudine; Macaca fascicularis; Male; Reverse Transcriptase Inhibitors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Tissue Distribution; Viremia; Zidovudine	2010
Impact of short-term HAART initiated during the chronic stage or shortly post-exposure on SIV infection of male genital organs. PloS one, 2012, Volume: 7, Issue:5 Topics: Animals; Antiretroviral Therapy, Highly Active; Genitalia, Male; Indinavir; Lamivudine; Macaca fascicularis; Male; RNA, Viral; Semen; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Viral Load; Zidovudine	2012
Indinavir Alters the Pharmacokinetics of Lamivudine Partially via Inhibition of Multidrug and Toxin Extrusion Protein 1 (MATE1). Pharmaceutical research, 2018, 01-04, Volume: 35, Issue:1 Topics: Animals; Anti-HIV Agents; Biological Transport; Cell Culture Techniques; Drug Interactions; HEK293 Cells; HIV-1; Humans; Indinavir; Kidney; Lamivudine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organic Cation Transport Proteins; Tissue Distribution	2018
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010